tolvaptan has been researched along with Hyponatremia in 247 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 41 (16.60) | 29.6817 |
| 2010's | 170 (68.83) | 24.3611 |
| 2020's | 36 (14.57) | 2.80 |
| Authors | Studies |
|---|---|
| Estilo, A; McCormick, L; Rahman, M | 1 |
| Gosch, M | 1 |
| Kawada, T | 1 |
| Honda, K; Inoue, D; Inoue, R; Nangaku, M; Nishi, H | 1 |
| Grossmann, M; Hoermann, R; Russell, N; Warren, AM; Zajac, JD | 1 |
| Bianchetti, MG; Lava, SAG; Leoni-Foglia, C; Milani, GP; Piffer, A; Simonetti, GD | 1 |
| Anceschi, C; Baldanzi, F; Fibbi, B; Maggi, M; Marroncini, G; Naldi, L; Peri, A | 1 |
| Delgado, A; Fernández-Alonso, V; Melero, R; Rodríguez-Benítez, P; Salcedo, M; Tejedor, M | 1 |
| Gannamani, V; Nathan, S; Ustun, C; Varma, A | 1 |
| Barajas Galindo, DE; de la Vega, IR; Fernández Martínez, A; Ferrer García, JC; Gómez Hoyos, E; Ortolá Buigues, A; Ropero-Luis, G; Ruiz-Sánchez, JG; Serrano Gotarredona, J | 1 |
| Adamo, V; Campo, S; Lacquaniti, A; Monardo, P; Russo, A | 1 |
| Bird-Lieberman, G; Bockenhauer, D; Gilbert, RD; Hoogenboom, L; Kumaran, A; Moon, RJ; Singh, J; Soliman, M | 1 |
| Gärtner, F; Jansen, O; Laudes, M; Reinke, LM; Rohmann, N; Schreiber, S; Schulte, DM; Seoudy, AK | 1 |
| Alexandrou, D; Amin, R; Bockenhauer, D; Dattani, M; Famuboni, A; Gan, HW; Lopez-Garcia, C; Shah, S; Trompeter, R; Veligratli, F | 1 |
| Aliberti, L; Ambrosio, MR; Bondanelli, M; Gagliardi, I; Zatelli, MC | 1 |
| Baba, K; Horikirizono, H; Igase, M; Kambayashi, S; Kimura, K; Mizuno, T; Okuda, M; Tamura, Y; Yamamoto, H | 1 |
| Chung, B; Fujino, T; Imamura, T; Jeevanandam, V; Kalantari, S; Kim, G; LaBuhn, C; Narang, N; Nguyen, A; Nitta, D; Raikhelkar, J; Rodgers, D; Sarswat, N; Sayer, G; Smith, B; Uriel, N | 1 |
| Barajas-Galindo, DE; Gómez-Hoyos, E; Guerra-González, M; Vidal-Casariego, A | 1 |
| Gwak, HS; Kim, Y; Lee, KE; Lee, N | 1 |
| Delbet, JD; Parmentier, C; Ulinski, T | 1 |
| Bartalesi, F; Bartoloni, A; Basile, G; Buci, L; Corti, G; Farese, A; Parenti, G; Peri, A; Piccica, M | 1 |
| Decaux, G; Gankam Kengne, F | 1 |
| Jhaveri, KD; Rondon-Berrios, H; Workeneh, BT | 1 |
| Elkayam, U; Fong, MW; Grazette, LP; Han, EE; Kuo, A; Lou, M; Mehra, A; Ng, TMH; Upadhyay, RY; Yoon, AJ | 1 |
| Flägel, K; Gosch, M; Hofmann, W | 1 |
| Arima, H; Goto, K; Hirano, T; Ishikawa, SE; Motozawa, T; Mouri, M; Watanabe, R | 1 |
| Basal, FB; Bilgetekin, I; Demirci, U; Erturk, I; Karacin, C; Karadurmus, N; Oksuzoglu, B | 1 |
| Attia, H; El-Shabrawy, M; Emad Aboulhoda, B; Emam, M; Mishriki, A; Wanas, H | 1 |
| Alukal, JJ; John, S; Thuluvath, PJ | 1 |
| de Jong-Laird, A; Kabra, M; Lindner, U; Pose-Reino, A; Runkle de la Vega, I | 1 |
| Alvear-Perez, R; Bonnet, D; De Mota, N; Estéoulle, L; Flahault, A; Girault-Sotias, PE; Iturrioz, X; Keck, M; Llorens-Cortes, C; Ramanoudjame, SM | 1 |
| Bonny, O; Martin, PY; Stucker, F | 1 |
| Al-Othman, S; Blackhall, F; Brabant, G; Chatzimavridou-Grigoriadou, V; Higham, CE; King, J; Kyriacou, A; Trainer, PJ | 1 |
| Kaku, Y; Nishimura, M; Saimiya, M | 1 |
| Bele, S; Bründl, E; Graf, B; Kerscher, C; Kieninger, M; Proescholdt, M; Schebesch, KM; Schmidt, NO; Zeman, F | 1 |
| Enomoto, N; Gotou, T; Hayashi, T; Higuchi, M; Itakura, J; Izumi, N; Komiyama, Y; Kubota, Y; Kurosaki, M; Nakanishi, H; Oh, W; Okada, M; Takada, H; Takahashi, Y; Takaura, K; Tamaki, N; Yasui, Y | 1 |
| Gustafsson, F; Vishram-Nielsen, JK | 1 |
| Boklage, S; Kamat, S; Mladsi, D; Ramamohan, V; Ronquest, N | 1 |
| De Sanctis, L; Einaudi, S; Matarazzo, P; Tessaris, D; Tuli, G | 1 |
| Damman, K; Fujii, H; Fukamizu, S; Goldsmith, SR; Kagiyama, N; Kitai, T; Matsue, Y; Nishioka, T; Noda, M; Onishi, Y; Ono, Y; Satoh, Y; Sugi, K; Suzuki, M; Ter Maaten, JM; Torii, S; van der Meer, P; Voors, AA; Yamaguchi, S; Yoshida, K | 1 |
| Aydın Kaderli, A; Aydınlar, A; Baran, İ; Çavuşoğlu, Y; Gül, BC; Güllülü, S; Özdemir, B; Sağ, S; Yıldız, A | 1 |
| Fujii, H; Fukamizu, S; Goldsmith, SR; Kagiyama, N; Kitai, T; Matsue, Y; Nishioka, T; Noda, M; Onishi, Y; Ono, Y; Satoh, Y; Sugi, K; Suzuki, M; Torii, S; Yamaguchi, S; Yoshida, K; Yoshioka, K | 1 |
| Isobe, M; Kamiyama, M; Masumura, M; Nomoto, H; Ohno, M; Oumi, T; Sakakibara, A; Satoh, Y; Sugiyama, T; Suzuki, M; Takahashi, Y; Yabe, K; Yamashita, S | 1 |
| Bricmont, P; Dandurand, A; Shoaf, SE | 1 |
| Kubota, T; Matsukawa, R; Meno, H; Okabe, M; Yamamoto, Y | 1 |
| Hashimoto, E; Ikarashi, Y; Kobayashi, M; Kodama, K; Kogiso, T; Taniai, M; Tokushige, K; Torii, N; Yamamoto, K | 1 |
| Koch, M; Schulz, C; Utpatel, K | 1 |
| Akashi, YJ; Inomata, T; Izumi, T; Kida, K; Sato, N; Shibagaki, Y; Tominaga, N | 1 |
| Kinugawa, K; Kugai, T; Nakamura, M; Sunagawa, O | 1 |
| Parekh, A; Patel, G; Rajaram, P; Subramanian, RM | 1 |
| Amin, AN; Chase, SL; Harmon, AL; Kamat, SA; Ortendahl, JD; Stellhorn, RA; Sundar, SV | 1 |
| Gonski, P; Grossmann, M; Obeid, J; Scholes, R; Topliss, DJ; Woodward, M | 1 |
| Kinugawa, K; Nakamura, M; Sunagawa, O | 1 |
| Fei, YH; Han, XB; Liu, YH; Xu, HT | 1 |
| Antonuzzo, A; Berardi, R; Blasi, L; Buosi, R; Lorusso, V; Migliorino, MR; Montesarchio, V; Peri, A; Sabbatini, R; Zilembo, N | 1 |
| Bhasin, B; Bohm, NM; Crawford, R; Kelley, D; Morris, JH; Nemecek, BD; Nietert, PJ; Velez, JCQ | 1 |
| Baturone, MO; Delgado, DA; León, RG; Ternero Vega, JE | 1 |
| Abe, K; Fujita, M; Hayashi, M; Ohira, H; Okai, K; Takahashi, A | 1 |
| Choi, HY; Ha, SK; Han, SW; Jeong, KH; Kang, KP; Kim, GH; Kim, HJ; Kim, HY; Kim, SW; Kim, YW; Shin, SK; Yi, JH | 1 |
| Fang, CY; Fang, HY; Lee, WC | 1 |
| Sterns, RH | 1 |
| Foppiani, L | 1 |
| Chase, S; Dasta, JF; Lin, J; Lingohr-Smith, M; Sundar, S | 1 |
| Ding, HG; Han, T; Li, Y; Liebe, R; Ma, H; Wang, S; Weng, H; Xie, W; Zhang, X | 1 |
| Gürbüz, F; Taştan, M; Turan, İ; Yüksel, B | 1 |
| Amin, A; Chiodo, JA; Sanyal, A; Sigal, SH | 1 |
| Peri, A | 2 |
| Ichikawa, D; Kai, K; Koitabashi, K; Shibagaki, Y; Tominaga, N | 1 |
| Kitchlu, A; Rosner, MH | 1 |
| Aggarwal, S; Garg, R; Kaur, K; Singh, N | 1 |
| Hatano, M; Imamura, T; Inaba, T; Kato, N; Kinugawa, K; Komuro, I; Kyo, S; Maki, H; Minatsuki, S; Muraoka, H; Ono, M; Shiga, T; Yao, A | 1 |
| Barnes, AP; Gonzalez, A; Koch, JD; Leonard, D; Quigley, R; Regen, RB; Zawodniak, K | 1 |
| Hori, M | 1 |
| Angelini, C; Arosio, P; Bertuzzi, A; Colombo, P; Cucchiari, D; De Sanctis, R; Faucher, E; Fusco, N; Pellegrinelli, A | 1 |
| Benso, A; Brandolin, I; Foppiani, L; Lo Pinto, G; Raggi, F; Tagliabue, M | 1 |
| Filmyer, DM; Geboy, AG; Josiassen, RC; Shaughnessy, RA | 1 |
| Greenberg, A; Lehrich, RW; Ortiz-Melo, DI; Patel, MB | 1 |
| Burnett, J; Gheorghiade, M; Grinfeld, L; Hauptman, PJ; Konstam, MA; Kostic, D; Krasa, HB; Maggioni, A; Ouyang, J; Swedberg, K; Udelson, JE; Zannad, F; Zimmer, C | 1 |
| Goldsmith, SR | 4 |
| Mager, DE; Mallikaarjun, S; Shoaf, SE; Van Wart, SA | 1 |
| Badjatia, N; Choi, HA; Claassen, J; Jeon, SB; Kim, MC; Lee, K; Lesch, C; Mayer, SA | 1 |
| Aghi, MK; Blevins, L; Jahangiri, A; Kunwar, S; Miller, LM; Tom, MW; Tran, MT; Wagner, J | 1 |
| Grohé, C; Lüders, H; Petereit, C; Teber, I; Zaba, O | 1 |
| Formiga, F; Navarro, A; Poch, E; Pose, A; Runkle, I; Tejedor, A; Villabona, C | 2 |
| Kilonzo, K; Lee, JJ; Nistico, A; Yeates, K | 1 |
| Iwao, H; Izumi, Y; Miura, K | 1 |
| Aberle, J; Burkhardt, T; Flitsch, J; Janneck, M; Rotermund, R; Sauer, N | 1 |
| Giuliani, C; Peri, A | 1 |
| Hatano, M; Imamura, T; Inaba, T; Kato, N; Kinugawa, K; Komuro, I; Maki, H; Minatsuki, S; Muraoka, H; Yao, A | 1 |
| Kwo, PY | 1 |
| Aoki, A; Asano, T; Ikoma, A; Ishikawa, SE; Kakei, M; Kusaka, I; Yamada, H; Yamashita, T; Yoshida, M | 1 |
| Arima, H; Banno, R; Fujisawa, H; Goto, M; Iwama, S; Izumida, H; Kiyota, A; Nakashima, K; Ochiai, H; Ogawa, K; Oiso, Y; Suga, H; Sugimura, Y; Suzuki, H; Takagi, H; Takeuchi, S | 1 |
| Almenar-Bonet, L; Martínez-Dolz, L; Rodríguez-de Muñoz, YM; Rodríguez-Serrano, M; Salvador-Sanz, A; Sánchez-Lázaro, IJ | 1 |
| Esteban-Fernández, A; García-López, M; Gavira-Gómez, JJ; Lavilla-Royo, FJ; Salterain-Gonzalez, N | 1 |
| Ali, N; George, M; Lahoti, A; Palla, S; Salahudeen, AK | 1 |
| Chen, S; Gu, F; Guo, XH; Liu, ZM; Ma, JH; Qiu, MC; Tong, NW; Yang, GY; Zhang, ZW; Zhao, JJ | 1 |
| Adhiyaman, V; Chattopadhyay, I; Williams, M | 1 |
| Ahluwalia, V; Bajaj, JS; Feldman, G; Gavis, E; Gilles, H; Heuman, DM; Thacker, LR; Unser, A; Wade, JB; White, MB | 1 |
| Han, E; Kang, HJ; Kim, HL; Lee, EK; Lee, MY; Park, SY | 1 |
| Ding, HG; Dong, PL; Fan, CL; Li, B; Li, L; Li, P; Wang, SZ; Zhang, X; Zhao, WM; Zheng, JF | 1 |
| Adams, KF; Lin, TE; Patterson, JH | 1 |
| Haas, CS | 1 |
| Fernández Catalina, P; Lorenzo Solar, M; Rego Iraeta, A; Sánchez Sobrino, P | 1 |
| Siegel, AJ | 1 |
| Amin, AN; Burst, VR; Chiodo, JA; Chiong, JR; Dasta, JF; Friend, KE; Greenberg, A; Hauptman, PJ; Peri, A; Sigal, SH; Verbalis, JG | 1 |
| Hori, M; Izumi, T; Kobayashi, H; Nakajima, K; Oka, H; Okita, K; Sakaida, I; Sakurai, M; Shibasaki, Y; Tachikawa, S; Tsubouchi, H | 1 |
| Ardizzoni, A; Bordi, P; Buti, S; Regolisti, G; Tiseo, M | 1 |
| Lindner, U; Schäffler, A | 1 |
| Bando, K; Inomata, T; Kinugawa, K; Mizuguchi, K; Sato, N; Shimakawa, T; Yasuda, M | 1 |
| Acaban, MB; Arı, H; Kahraman, F | 1 |
| Tanındı, A; Töre, HF | 1 |
| Hensen, J | 4 |
| Ayuk, J; Bouloux, PM; Cohen, M; Cranston, I; Grant, P; Grossman, A; Murray, RD; Rees, A; Thatcher, N | 1 |
| Blau, W; Brock, J; Gattenlöhner, S; Karrasch, T; Nilles, M; Roller, FC; Roller, FF; Schäffler, A; Steiner, D | 1 |
| Balla, A; Erdélyi, LS; Groß, U; Hunyady, L; Mann, WA; Morris-Rosendahl, DJ; Nagel, M; Várnai, P | 1 |
| Aylwin, S; Burst, V; Peri, A; Runkle, I; Thatcher, N | 1 |
| Cao, Y; Deng, S; Huang, J; Huang, Y; Qian, J; Rong, S; Tan, J; Wang, C; Xiong, B; Yao, Y; Zou, Y | 1 |
| Hatano, M; Imamura, T; Kimura, M; Kinoshita, O; Kinugawa, K; Nawata, K; Ono, M | 1 |
| Bagkeris, E; Bouloux, PM; Carr, H; Cohen, M; Khoo, B; Tzoulis, P; Waung, JA | 1 |
| Camps Herrero, C; Carcereny, E; De Las Peñas, R; Escobar Álvarez, Y; Henao, F; López López, R; Ponce, S; Rodríguez, CA; Virizuela, JA | 1 |
| Inukai, S; Ito, K; Kato, T; Nagasaki, R; Saitoh, S; Sato, N; Sugiura, T; Suzuki, K | 1 |
| Angelico, M; Baiocchi, L; Lenci, I; Milana, M | 1 |
| Cheungpasitporn, W; Enders, F; Erickson, SB; Lieske, JC; Rule, AD | 1 |
| Czerwiec, FS; Ellison, H; Hobart, M; Krasa, H; Ouyang, J; Verbalis, JG | 1 |
| Arici, M; Benzing, T; Birn, H; Capasso, G; Covic, A; Devuyst, O; Drechsler, C; Eckardt, KU; Emma, F; Gansevoort, RT; Knebelmann, B; Le Meur, Y; Massy, ZA; Ong, AC; Ortiz, A; Schaefer, F; Torra, R; Van Biesen, W; Vanholder, R; Więcek, A; Zoccali, C | 1 |
| Haas, CS; Harbeck, B; Lindner, U | 1 |
| Hashimoto, Y; Kagiyama, N; Kume, T; Matsue, Y; Matsumura, A; Okura, H; Suzuki, M; Yoshida, K; Yoshioka, K | 1 |
| Dohi, K; Fujimoto, N; Ito, M; Kumagai, N; Nakamori, S; Ogura, T; Sato, Y; Sugimoto, T; Sugiura, E; Takeuchi, T; Tanimura, M; Watanabe, K; Yamada, N | 1 |
| Anjaneyan, K; Doss, CR; George, M; Jena, A; Kanagesh, B; Rajaram, M; Ramaraj, B; Shanmugam, E | 1 |
| Gisby, M; Jamookeeah, C; Ländin, M; Lundberg, J; O'Reilly, K; Robinson, P; Skov, J; Trueman, D | 1 |
| Hayata, Y; Ito, D; Karasawa, Y; Kawamura, S; Kojima, K; Ohki, T; Seki, M; Tagawa, K; Toda, N; Yamada, T | 1 |
| Fang, D; Feng, H; Li, B; Qian, C; Wang, Y | 1 |
| Llompart-Pou, JA; Novo, M; Pérez-Bárcena, J; Raurich, JM | 1 |
| Tesař, V | 1 |
| Bockenhauer, D | 1 |
| Bhandari, S; Cranston, I; Glanville, J; McCool, R; O'Reilly, K; Peri, A; Petrakova, L; Shaw, A | 1 |
| Ahmad, F; Blais, JD; Chiodo, J; Czerwiec, FS; Glaser, LA; Gralla, RJ; Zhou, W | 1 |
| Jung, MC; Kim, HJ; Kim, JK; Kim, SG; Lee, CM; Park, GH; Song, JW; Song, YR | 1 |
| Berger, K; Der-Nigoghossian, C; Lesch, C | 1 |
| Laczi, F | 1 |
| Albazzaz, A; Czerwiec, F; Goldman, M; Jessani, M; Josiassen, RC; Lee, J; Orlandi, C; Ouyang, J; Shaughnessy, RA | 1 |
| Farmakis, D; Filippatos, G; Gheorghiade, M; Kremastinos, DT; Parissis, J | 1 |
| Farmakis, D; Filippatos, G; Gheorghiade, M; Kremastinos, DT | 1 |
| Whellan, DJ | 1 |
| Cavalcante, JL; Gheorghiade, M; Khan, S | 1 |
| Gross, P; Herbrig, K; Marczewski, T | 1 |
| Krahn, TA; Mount, DB | 1 |
| Thompson, CA | 1 |
| Ghali, JK; Hamad, B; Kirkpatrick, P; Yasothan, U | 1 |
| Haass, M | 1 |
| Huynh-Do, U; Stober, CN | 1 |
| Boyer, TD | 1 |
| Audino, B; Curtis, J; Filmyer, DM; Josiassen, RC; Shaughnessy, RA; Skuban, N | 1 |
| Sherlock, M; Thompson, CJ | 1 |
| Greenberg, A; Lehrich, RW | 1 |
| Berl, T; Bichet, DG; Czerwiec, FS; Ouyang, J; Quittnat-Pelletier, F; Schrier, RW; Verbalis, JG | 1 |
| Plosker, GL | 1 |
| Reilly, T; Schork, MR | 1 |
| Fujiki, H; Hirose, T; Miyazaki, T; Ohmoto, K | 1 |
| Thompson, CJ | 1 |
| Ghali, JK; Tam, SW | 1 |
| Ferrer, E | 1 |
| Carluccio, AL; Merlin, MA; Zenenberg, RD | 1 |
| Gafter, U; Gheorghiade, M; Korzets, A; Leibovici, L; Rozen-Zvi, B; Yahav, D | 1 |
| Hutchinson, DJ; Nemerovski, C | 1 |
| Goldman, MB | 1 |
| Komai, Y; Palaniyandi, SS; Sukumaran, V; Thandavarayan, RA; Veeraveedu, PT; Watanabe, K; Yamaguchi, K | 1 |
| Alivanis, P; Aperis, G | 1 |
| Singh, M; Slawsky, MT; Valania, G | 1 |
| Amin, A; Meeran, K | 1 |
| Chiong, JR; Jao, GT | 1 |
| Cantillo, DS; Comín Colet, J; Robledo, GG | 1 |
| Villabona, C | 1 |
| Hix, J; Sterns, R | 1 |
| Elhassan, EA; Schrier, RW | 1 |
| Robertson, GL | 1 |
| Cyr, PL; Goss, TF; Hauptman, PJ; Krasa, HB; Olchanski, N; Slawsky, KA; Zimmer, C | 1 |
| Ambrosy, A; Gheorghiade, M; Goldsmith, SR | 1 |
| Grant, P | 1 |
| Decaux, G; Gross, PA; Wagner, A | 1 |
| DeVita, MV; Michelis, MF; Vaghasiya, RP | 1 |
| Cohen, AF; Dubois, EA; Rissmann, R | 1 |
| Cassagnol, M; Saad, M; Shogbon, AO | 1 |
| Benzing, T; Gross, P; Hensen, J; Mönig, H | 1 |
| Deitelzweig, SB; McCormick, L | 1 |
| Afdhal, NH; Cárdenas, A; Czerwiec, F; Ginès, P; Guevara, M; Marotta, P; Oyuang, J | 1 |
| Cho, C; Lien, YH; Logan, JL | 1 |
| Gargani, L; Gheorghiade, M; Schmidt, PH | 1 |
| Kettritz, R; Luft, FC | 1 |
| Chiong, JR; Christian, R; Dasta, JF; Kim, S; Lin, J | 1 |
| Bai, H; Li, L; Zhu, WL | 1 |
| Caimi, G; Urso, C | 1 |
| Coffernils, M; Couturier, B; Decaux, G; Gankam-Kengne, F; Soupart, A | 1 |
| Chiong, JR; Christian, R; Dasta, JF; Lin, J | 1 |
| Alemayehu, A; O'Connell, JB | 1 |
| Curtis, JL; Czerwiec, F; Filmyer, DM; Geboy, AG; Josiassen, RC; Ouyang, J; Shaughnessy, RA; Skuban, N | 1 |
| Combe, C; Peri, A | 1 |
| Bouloux, PM; Burst, V; Hoorn, EJ | 1 |
| Frank, D; Janssens, U; Meyer, I | 1 |
| Castillo, JJ; Justice, E; Vincent, M | 1 |
| Chiodo, J; Gaglio, P; Marfo, K | 1 |
| Grossman, AB; Kar, P; Rajendran, R | 1 |
| Dabrowska, MD; Krysiak, R; Okopień, B | 1 |
| Cowie, F; Hannaway, RK; Jude, E | 1 |
| Cirulli, J; Friedman, B | 1 |
| Dahl, E; Gluud, LL; Kimer, N; Krag, A | 1 |
| Cassidy, IB; Chiong, JR; Christian, R; Dasta, JF; Friend, K; Lin, J; Lingohr-Smith, M | 1 |
| Berl, T; Jovanovich, AJ | 1 |
| Endo, M; Hatano, M; Hirata, Y; Imamura, T; Inaba, T; Kato, N; Kinugawa, K; Kyo, S; Maki, H; Nagai, R; Nishimura, T; Ono, M; Shiga, T; Yao, A | 1 |
| Saab, S; Sharma, N; Yu, C | 1 |
| Czerwiec, F; Gheorghiade, M; Kambayashi, J; Niazi, I; Orlandi, C; Ouyang, J; Zampino, M | 1 |
| Fujiki, H; Kinoshita, S; Miyazaki, T; Mori, T; Nakamura, S; Nakayama, S; Onogawa, T; Yamamura, Y | 1 |
| Czerwiec, F; Gheorghiade, M; Gottlieb, SS; Konstam, MA; Orlandi, C; Ouyang, J; Udelson, JE | 1 |
| Pham, PC; Pham, PM; Pham, PT | 1 |
| Greenberg, A; Verbalis, JG | 1 |
| Gross, P; Quittnat, F | 1 |
| Gross, P; Herbrig, K; Palm, C; Pistrosch, F | 1 |
| Verbalis, JG | 1 |
| Hays, RM | 1 |
| Berl, T; Czerwiec, FS; Gheorghiade, M; Gross, P; Orlandi, C; Schrier, RW; Verbalis, JG | 1 |
| Batlle, D; Chen, S; Jalandhara, N | 1 |
| Hood, VL; Rimmer, JM; Weise, WJ | 1 |
| Dawwas, MF | 1 |
| Hoorn, EJ; Zietse, R | 1 |
| Arici, M; Kirkpantur, A; Ozkan, C | 1 |
| Ali, F; Ghali, JK; Guglin, M; Vaitkevicius, P | 1 |
| Bolignano, D; Buemi, M; Campo, S; Coppolino, G; Criseo, M; Romeo, A | 1 |
| Fujiki, H; Miyazaki, T; Mori, T; Nakamura, S; Yamamura, Y | 1 |
| Harman, C | 1 |
| Balk, RA; Patel, GP | 1 |
| Fujiki, H; Sato, O; Yamamura, Y | 1 |
| Adams, KF; Bayram, M; Gheorghiade, M; Lloyd-Jones, D; Oconnor, CM; Orlandi, C; Ouyang, J; Rossi, J; Shin, DD; Stough, WG; Udelson, JE | 1 |
| Madias, NE | 1 |
| Kumar, S; Mather, PJ; Rubin, S; Whellan, DJ | 1 |
| Haskal, R | 1 |
| Głuszek, J; Olszewski, W | 1 |
| Schweiger, TA; Zdanowicz, MM | 1 |
86 review(s) available for tolvaptan and Hyponatremia
| Article | Year |
|---|---|
Vaptans for oedematous and hyponatraemic disorders in childhood: A systematic literature review.
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Child; Diuretics; Heart Failure; Humans; Hyponatremia; Sodium; Tolvaptan | 2022 |
Tolvaptan and urea in paediatric hyponatraemia.
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Child; Humans; Hyponatremia; Inappropriate ADH Syndrome; Sodium; Tolvaptan; Treatment Outcome; Urea | 2024 |
Hypertonic saline, isotonic saline, water restriction, long loops diuretics, urea or vaptans to treat hyponatremia.
Topics: Acute Disease; Antidiuretic Hormone Receptor Antagonists; Bicarbonates; Chronic Disease; Drinking; Humans; Hyponatremia; Practice Guidelines as Topic; Saline Solution; Saline Solution, Hypertonic; Sodium; Sodium Potassium Chloride Symporter Inhibitors; Tolvaptan; Urea; Uric Acid | 2020 |
Hyponatremia in the cancer patient.
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Humans; Hyponatremia; Inappropriate ADH Syndrome; Neoplasms; Quality of Life; Tolvaptan | 2020 |
Hyponatremia in Cirrhosis: An Update.
Topics: Acute Kidney Injury; Acute-On-Chronic Liver Failure; Albumins; Antidiuretic Hormone Receptor Antagonists; Ascites; Fluid Therapy; Hepatic Encephalopathy; Hepatorenal Syndrome; Humans; Hypertension, Portal; Hyponatremia; Liver Cirrhosis; Liver Transplantation; Renin-Angiotensin System; Saline Solution, Hypertonic; Splanchnic Circulation; Tolvaptan; Vasodilation; Vasopressins | 2020 |
[Clinical use of tolvaptan: a 2021 review].
Topics: Disease Progression; Drug-Related Side Effects and Adverse Reactions; Humans; Hyponatremia; Inappropriate ADH Syndrome; Tolvaptan | 2021 |
Vasopressin and Vasopressin Antagonists in Heart Failure.
Topics: Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Glycopeptides; Heart Failure; Hemodynamics; Humans; Hyponatremia; Receptors, Vasopressin; Tolvaptan; Vasopressins | 2017 |
Tolvaptan Treatment in Children with Chronic Hyponatremia due to Inappropriate Antidiuretic Hormone Secretion: A Report of Three Cases
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Child; Child, Preschool; Female; Humans; Hyponatremia; Inappropriate ADH Syndrome; Male; Tolvaptan | 2017 |
Diagnosis and management of hyponatraemia in the older patient.
Topics: Aged; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Health Services for the Aged; Humans; Hyponatremia; Residential Facilities; Tolvaptan; Treatment Outcome | 2018 |
Practical issues for the management of hyponatremia in oncology.
Topics: Antidiuretic Hormone Receptor Antagonists; Disease Management; Humans; Hyponatremia; Inappropriate ADH Syndrome; Neoplasms; Tolvaptan | 2018 |
Management of hyponatremia: causes, clinical aspects, differential diagnosis and treatment.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Awareness; Diagnosis, Differential; Electrolytes; Female; Gait; Health Status Disparities; Humans; Hyponatremia; Inappropriate ADH Syndrome; Male; Models, Animal; Mutation; Rats; Receptors, Vasopressin; Tolvaptan | 2019 |
Hyponatremia in patients with cancer.
Topics: Fluid Therapy; Humans; Hyponatremia; Inappropriate ADH Syndrome; Neoplasms; Tolvaptan | 2019 |
Role of vaptans in the management of hyponatremia.
Topics: Antidiuretic Hormone Receptor Antagonists; Benzamides; Benzazepines; Humans; Hyponatremia; Male; Middle Aged; Pyrroles; Tolvaptan | 2013 |
Management of hyponatremia.
Topics: Antidiuretic Hormone Receptor Antagonists; Benzamides; Benzazepines; Disease Management; Female; Humans; Hyponatremia; Hypovolemia; Inappropriate ADH Syndrome; Male; Morpholines; Prognosis; Pyrroles; Receptors, Vasopressin; Risk Assessment; Severity of Illness Index; Spiro Compounds; Tolvaptan; Treatment Outcome | 2014 |
Therapeutic potential of vasopressin-receptor antagonists in heart failure.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzamides; Benzazepines; Body Water; Clinical Trials as Topic; Disease Models, Animal; Heart Failure; Homeostasis; Humans; Hyponatremia; Morpholines; Pyrroles; Receptors, Vasopressin; Spiro Compounds; Tolvaptan; Ventricular Remodeling | 2014 |
Hyponatremia after trans-sphenoidal surgery.
Topics: Benzazepines; Humans; Hyponatremia; Hypophysectomy; Inappropriate ADH Syndrome; Pituitary Diseases; Pituitary Gland, Posterior; Postoperative Period; Prevalence; Saline Solution, Hypertonic; Sphenoid Bone; Tolvaptan | 2014 |
Management of euvolemic hyponatremia attributed to SIADH in the hospital setting.
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Blood Volume; Body Water; Chemical and Drug Induced Liver Injury; Clinical Trials as Topic; Demeclocycline; Diabetes Insipidus, Nephrogenic; Disease Management; Drug Interactions; Hospitalization; Humans; Hydrocortisone; Hyponatremia; Hypothyroidism; Inappropriate ADH Syndrome; Kidney Tubules, Collecting; Lithium; Multicenter Studies as Topic; Osmolar Concentration; Paraneoplastic Syndromes; Saline Solution, Hypertonic; Tolvaptan | 2014 |
Potential roles of vaptans in heart failure: experience from clinical trials and considerations for optimizing therapy in target patients.
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Clinical Trials as Topic; Heart Failure; Humans; Hyponatremia; Prospective Studies; Tolvaptan; Vasopressins | 2014 |
[Use of "Vaptans" in treatment of hyponatremia].
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Contraindications; Humans; Hyponatremia; Tolvaptan | 2015 |
The short-term and long-term effects of tolvaptan in patients with heart failure: a meta-analysis of randomized controlled trials.
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Body Weight; Creatinine; Heart Failure; Humans; Hyponatremia; Potassium; Randomized Controlled Trials as Topic; Sodium; Time Factors; Tolvaptan | 2015 |
Recommendations for the use of tolvaptan in autosomal dominant polycystic kidney disease: a position statement on behalf of the ERA-EDTA Working Groups on Inherited Kidney Disorders and European Renal Best Practice.
Topics: Adult; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Disease Progression; Europe; Humans; Hyponatremia; Polycystic Kidney, Autosomal Dominant; Societies, Medical; Tolvaptan | 2016 |
The Efficacy and Safety of Tolvaptan in Patients with Hyponatremia: A Meta-Analysis of Randomized Controlled Trials.
Topics: Benzazepines; Blood Pressure; Humans; Hyponatremia; Randomized Controlled Trials as Topic; Risk; Sodium; Tolvaptan | 2017 |
A systematic review of known interventions for the treatment of chronic nonhypovolaemic hypotonic hyponatraemia and a meta-analysis of the vaptans.
Topics: Antidiuretic Hormone Receptor Antagonists; Benzamides; Benzazepines; Humans; Hyponatremia; Morpholines; Osmotic Pressure; Pyrroles; Randomized Controlled Trials as Topic; Receptors, Vasopressin; Spiro Compounds; Tolvaptan | 2017 |
[Etiology, diagnostics and therapy of hyponatremias].
Topics: Antidiuretic Hormone Receptor Antagonists; Azepines; Benzamides; Benzazepines; Blood Volume; Brain Diseases; Central Nervous System; Chronic Disease; Demeclocycline; Demyelinating Diseases; Diagnosis, Differential; Diuretics; Extracellular Fluid; Furosemide; Humans; Hyponatremia; Inappropriate ADH Syndrome; Lithium Compounds; Morpholines; Osmolar Concentration; Osmosis; Pyrroles; Severity of Illness Index; Sodium; Spiro Compounds; Time Factors; Tolvaptan; Vasopressins | 2008 |
Hyponatremia in heart failure.
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Heart Failure; Humans; Hyponatremia; Prognosis; Sodium; Tolvaptan; Treatment Outcome; Vasopressins | 2009 |
Vasopressin and vasopressin antagonists in heart failure and hyponatremia.
Topics: Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Azepines; Benzamides; Benzazepines; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Heart Failure; Humans; Hyponatremia; Infusions, Intravenous; Male; Prognosis; Pyrroles; Randomized Controlled Trials as Topic; Receptors, Vasopressin; Risk Assessment; Survival Rate; Tolvaptan; Water-Electrolyte Imbalance | 2008 |
Treatment options for hyponatremia in heart failure.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Azepines; Benzamides; Benzazepines; Heart Failure; Humans; Hyponatremia; Inappropriate ADH Syndrome; Pyrroles; Sodium Potassium Chloride Symporter Inhibitors; Tolvaptan; Treatment Outcome | 2009 |
[Vasopressin receptor antagonists and heart failure].
Topics: Administration, Oral; Aged; Antidiuretic Hormone Receptor Antagonists; Azepines; Benzamides; Benzazepines; Controlled Clinical Trials as Topic; Female; Follow-Up Studies; Furosemide; Heart Failure; Hormone Antagonists; Humans; Hyponatremia; Indoles; Male; Morpholines; Platelet Aggregation Inhibitors; Pyrroles; Pyrrolidines; Sodium Potassium Chloride Symporter Inhibitors; Spiro Compounds; Time Factors; Tolvaptan | 2009 |
[Treating hyponatraemia--not an easy task].
Topics: Administration, Oral; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Brain Edema; Chronic Disease; Clinical Trials as Topic; Female; Humans; Hyponatremia; Inpatients; Magnetic Resonance Imaging; Myelinolysis, Central Pontine; Sodium; Sodium Chloride; Time Factors; Tolvaptan; Tomography, X-Ray Computed | 2009 |
Tolvaptan: a new tool for the effective treatment of hyponatremia in psychotic disorders.
Topics: Antidiuretic Hormone Receptor Antagonists; Antipsychotic Agents; Benzazepines; Comorbidity; Humans; Hyponatremia; Inappropriate ADH Syndrome; Prevalence; Psychotic Disorders; Tolvaptan | 2010 |
The syndrome of inappropriate antidiuretic hormone: current and future management options.
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Clinical Trials as Topic; Disease Management; Forecasting; Humans; Hyponatremia; Inappropriate ADH Syndrome; Receptors, Vasopressin; Tolvaptan; Treatment Outcome | 2010 |
Tolvaptan.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Humans; Hyponatremia; Tolvaptan | 2010 |
Tolvaptan (Samsca) for hyponatremia.
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Cardiomyopathy, Dilated; Clinical Trials as Topic; Drug Approval; Drug Interactions; Humans; Hyponatremia; Inappropriate ADH Syndrome; Liver Cirrhosis; Osmolar Concentration; Tolvaptan; United States; United States Food and Drug Administration | 2009 |
Vasopressin antagonists: Pharmacotherapy for the treatment of heart failure.
Topics: Azepines; Benzamides; Benzazepines; Heart Failure; Humans; Hyponatremia; Neurotransmitter Agents; Pyrroles; Tolvaptan; Vasopressins | 2010 |
The critical link of hypervolemia and hyponatremia in heart failure and the potential role of arginine vasopressin antagonists.
Topics: Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzamides; Benzazepines; Blood Pressure; Blood Volume; Female; Heart Failure; Humans; Hypertension; Hyponatremia; Male; Prevalence; Prognosis; Pyrroles; Receptors, Vasopressin; Tolvaptan; United States; Water-Electrolyte Balance | 2010 |
Tolvaptan for the treatment of hyponatremia and congestive heart failure.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Clinical Trials, Phase III as Topic; Drug Evaluation, Preclinical; Heart Failure; Humans; Hyponatremia; Tolvaptan | 2010 |
Hyponatremia: evaluation and management.
Topics: Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Blood Urea Nitrogen; Cardiac Output, Low; Causality; Diagnosis, Differential; Glomerular Filtration Rate; Humans; Hyponatremia; Inappropriate ADH Syndrome; Kidney Tubules; Saline Solution, Hypertonic; Sodium; Tolvaptan; Uric Acid; Water-Electrolyte Balance | 2010 |
Vasopressin receptor antagonists for the treatment of hyponatremia: systematic review and meta-analysis.
Topics: Antidiuretic Hormone Receptor Antagonists; Azepines; Benzamides; Benzazepines; Humans; Hyponatremia; Morpholines; Pyrroles; Randomized Controlled Trials as Topic; Spiro Compounds; Tolvaptan; Treatment Outcome | 2010 |
Treatment of hypervolemic or euvolemic hyponatremia associated with heart failure, cirrhosis, or the syndrome of inappropriate antidiuretic hormone with tolvaptan: a clinical review.
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Blood Volume; Dose-Response Relationship, Drug; Drug Interactions; Heart Failure; Humans; Hyponatremia; Inappropriate ADH Syndrome; Liver Cirrhosis; Randomized Controlled Trials as Topic; Sodium; Tolvaptan | 2010 |
The assessment and treatment of water imbalance in patients with psychosis.
Topics: Antidiuretic Hormone Receptor Antagonists; Antimanic Agents; Antipsychotic Agents; Benzazepines; Clozapine; Combined Modality Therapy; Diagnosis, Differential; Drinking; Humans; Hyponatremia; Lithium Carbonate; Randomized Controlled Trials as Topic; Receptors, Vasopressin; Risk Factors; Schizophrenia; Schizophrenic Psychology; Sodium Chloride Symporter Inhibitors; Tolvaptan; Water Deprivation; Water Intoxication; Water-Electrolyte Balance | 2010 |
Treatment options for hyponatremia in heart failure.
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Biomarkers; Blood Volume; Heart Failure; Humans; Hyponatremia; Inappropriate ADH Syndrome; Signal Transduction; Tolvaptan | 2010 |
Arginine vasopressin receptor antagonists (vaptans): pharmacological tools and potential therapeutic agents.
Topics: Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Clinical Trials as Topic; Drug Evaluation, Preclinical; Heart Failure; Humans; Hyponatremia; Receptors, Vasopressin; Sodium Potassium Chloride Symporter Inhibitors; Tolvaptan | 2010 |
Tolvaptan: a new therapeutic agent.
Topics: Benzazepines; Humans; Hyponatremia; Tolvaptan | 2011 |
Targeting hyponatremia and hemodynamics in acute decompensated heart failure: is there a role for vasopressin antagonists?
Topics: Acute Disease; Animals; Antidiuretic Hormone Receptor Antagonists; Benzamides; Benzazepines; Clinical Trials as Topic; Heart Failure; Hemodynamics; Humans; Hyponatremia; Prognosis; Pyrroles; Tolvaptan; Vasoconstriction; Vasopressins | 2011 |
Hyponatremia in acute decompensated heart failure: mechanisms, prognosis, and treatment options.
Topics: Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Biomarkers; Fluid Therapy; Heart Failure; Hormone Antagonists; Humans; Hyponatremia; Receptors, Vasopressin; Renin-Angiotensin System; Sodium; Tolvaptan; Treatment Outcome; Ventricular Dysfunction | 2010 |
[Treatment of hyponatremia: role of vaptans].
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Brain Edema; Humans; Hyponatremia; Inappropriate ADH Syndrome; Neurologic Examination; Risk Factors; Saline Solution, Hypertonic; Sodium; Tolvaptan; Water-Electrolyte Balance | 2010 |
[Hyponatremia in heart failure: physiopathology and pharmacological approach].
Topics: Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzamides; Benzazepines; Body Water; Brain Edema; Demyelinating Diseases; Diuresis; Diuretics; Double-Blind Method; Heart Failure; Humans; Hyponatremia; Kidney; Multicenter Studies as Topic; Natriuresis; Pyrroles; Randomized Controlled Trials as Topic; Receptors, Vasopressin; Renin-Angiotensin System; Saline Solution, Hypertonic; Sympathetic Nervous System; Tolvaptan | 2010 |
[Vasopressin receptor antagonists: the vaptans].
Topics: Adult; Antidiuretic Hormone Receptor Antagonists; Aquaporin 2; Benzamides; Benzazepines; Calcium Signaling; Clinical Trials as Topic; Cyclic AMP; Double-Blind Method; Drug Therapy, Combination; Heart Failure; Humans; Hyponatremia; Inappropriate ADH Syndrome; Kidney Tubules, Collecting; Liver Cirrhosis; Morpholines; Multicenter Studies as Topic; Neoplasms; Pituitary Gland, Anterior; Pyrroles; Randomized Controlled Trials as Topic; Receptors, Vasopressin; Second Messenger Systems; Spiro Compounds; Tolvaptan; Vasopressins | 2010 |
Hyponatremia: diagnosis, complications, and management including V2 receptor antagonists.
Topics: Adaptation, Physiological; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Brain; Exercise; Heart Failure; Humans; Hyponatremia; Inappropriate ADH Syndrome; Liver Cirrhosis; Tolvaptan | 2011 |
Vaptans for the treatment of hyponatremia.
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Humans; Hyponatremia; Tolvaptan | 2011 |
Tolvaptan for the treatment of heart failure: a review of the literature.
Topics: Animals; Benzazepines; Clinical Trials as Topic; Consensus; Disease Models, Animal; Diuresis; Diuretics; Heart Failure; Humans; Hyponatremia; Tolvaptan; Toxicity Tests; Treatment Outcome | 2011 |
Vaptans are not the mainstay of treatment in hyponatremia: perhaps not yet.
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Drug Costs; Humans; Hyponatremia; Inappropriate ADH Syndrome; Tolvaptan | 2011 |
[Treatment of hyponatremia: new developments and controversies].
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Blood Volume; Drinking; Humans; Hyponatremia; Inappropriate ADH Syndrome; Saline Solution, Hypertonic; Sodium; Sodium Chloride; Sodium Chloride Symporter Inhibitors; Tolvaptan; Urea | 2011 |
The therapeutic use of vaptans for the treatment of dilutional hyponatremia.
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Clinical Trials as Topic; Drug Interactions; Humans; Hyponatremia; Receptors, Vasopressin; Tolvaptan; Water-Electrolyte Balance | 2011 |
[Practical approach to hyponatremia].
Topics: Aged; Benzazepines; Carcinoma, Small Cell; Combined Modality Therapy; Critical Pathways; Diagnosis, Differential; Drinking; Female; Humans; Hyponatremia; Inappropriate ADH Syndrome; Lung Neoplasms; Sodium; Tolvaptan | 2011 |
Hyponatremia in hospitalized patients: the potential role of tolvaptan.
Topics: Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Diagnosis, Differential; Hospitalization; Humans; Hyponatremia; Hypovolemia; Quality Indicators, Health Care; Severity of Illness Index; Time Factors; Tolvaptan | 2011 |
Tolvaptan for the treatment of hyponatremia secondary to the syndrome of inappropriate antidiuretic hormone secretion.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Hormone Antagonists; Humans; Hyponatremia; Inappropriate ADH Syndrome; Severity of Illness Index; Tolvaptan | 2011 |
[Disorders of fluid and electrolyte balance].
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Deamino Arginine Vasopressin; Humans; Hyperkalemia; Hypernatremia; Hyponatremia; Inappropriate ADH Syndrome; Membrane Potentials; Morpholines; Osmolar Concentration; Potassium; Randomized Controlled Trials as Topic; Sodium; Spiro Compounds; Survival Rate; Tolvaptan; Water-Electrolyte Imbalance | 2011 |
[Hyponatremic syndrome].
Topics: Aging; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Brain; Brain Edema; Exercise; Humans; Hyponatremia; Inappropriate ADH Syndrome; Infections; Inflammation; Kidney; Natriuresis; Neoplasms; Osmotic Pressure; Renal Replacement Therapy; Sodium; Tolvaptan; Water Intoxication | 2012 |
Hyponatremia, heart failure, and the role of tolvaptan.
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Diagnosis, Differential; Heart Failure; Humans; Hyponatremia; Prognosis; Tolvaptan; Treatment Outcome | 2012 |
Diagnosis and management of hyponatremia in cancer patients.
Topics: Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Disease Management; Humans; Hyponatremia; Hypovolemia; Inappropriate ADH Syndrome; Neoplasms; Receptors, Vasopressin; Risk Factors; Sodium; Tolvaptan | 2012 |
Hyponatremia in cirrhosis and end-stage liver disease: treatment with the vasopressin V₂-receptor antagonist tolvaptan.
Topics: Benzazepines; End Stage Liver Disease; Humans; Hyponatremia; Liver Cirrhosis; Liver Transplantation; Outcome Assessment, Health Care; Tolvaptan | 2012 |
[Hyponatremic hypervolemia in heart failure--the hot spot for vasopressin receptor antagonists?].
Topics: Antidiuretic Hormone Receptor Antagonists; Benzamides; Benzazepines; Diuretics; Heart Failure; Humans; Hyponatremia; Hypovolemia; Morpholines; Pyrroles; Spiro Compounds; Tolvaptan | 2012 |
Hyponatremia in critical care patients: frequency, outcome, characteristics, and treatment with the vasopressin V2-receptor antagonist tolvaptan.
Topics: Age Factors; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Body Temperature; Creatinine; Critical Care; Health Status Indicators; Humans; Hyponatremia; Intensive Care Units; Prevalence; Tolvaptan; Water-Electrolyte Imbalance | 2013 |
Meta-analysis: the safety and efficacy of vaptans (tolvaptan, satavaptan and lixivaptan) in cirrhosis with ascites or hyponatraemia.
Topics: Antidiuretic Hormone Receptor Antagonists; Ascites; Benzamides; Benzazepines; Humans; Hyponatremia; Liver Cirrhosis; Morpholines; Pyrroles; Randomized Controlled Trials as Topic; Receptors, Vasopressin; Sodium; Spiro Compounds; Tolvaptan; Treatment Outcome | 2012 |
[Hyponatremia : The water-intolerant patient].
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Brain Edema; Chronic Disease; Diagnosis, Differential; Hyponatremia; Inappropriate ADH Syndrome; Infusions, Intravenous; Intensive Care Units; Neurologic Examination; Prognosis; Risk Factors; Saline Solution, Hypertonic; Survival Analysis; Tolvaptan | 2012 |
Update on tolvaptan for the treatment of hyponatremia.
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Comparative Effectiveness Research; Cost-Benefit Analysis; Drug Costs; Hospitalization; Humans; Hyponatremia; Tolvaptan; Treatment Outcome | 2012 |
Where vaptans do and do not fit in the treatment of hyponatremia.
Topics: Acute Disease; Animals; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Biomarkers; Chronic Disease; Drug Costs; Hormone Antagonists; Humans; Hyponatremia; Receptors, Vasopressin; Sodium; Tolvaptan; Treatment Outcome | 2013 |
Hyponatremia: clinical associations, prognosis, and treatment in cirrhosis.
Topics: Benzazepines; Comorbidity; Hepatic Encephalopathy; Hepatorenal Syndrome; Humans; Hyponatremia; Liver Cirrhosis; Liver Transplantation; Prevalence; Prognosis; Sodium; Tolvaptan | 2013 |
Clinical review: the use of vaptans in clinical endocrinology.
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Clinical Trials as Topic; Drug Discovery; Endocrinology; Hormone Antagonists; Humans; Hyponatremia; Inappropriate ADH Syndrome; Models, Biological; Tolvaptan | 2013 |
Vasopressin excess and hyponatremia.
Topics: Arginine Vasopressin; Azepines; Benzamides; Benzazepines; Humans; Hyponatremia; Pyrroles; Receptors, Vasopressin; Tolvaptan; Water-Electrolyte Balance | 2006 |
Vasopressin receptor antagonists.
Topics: Antidiuretic Hormone Receptor Antagonists; Azepines; Benzamides; Benzazepines; Clinical Trials as Topic; Diabetes Insipidus, Nephrogenic; Fibrosis; Heart Failure; Humans; Hyponatremia; Osmolar Concentration; Polycystic Kidney Diseases; Pyrroles; Receptors, Vasopressin; Sodium; Tolvaptan; United States; United States Food and Drug Administration; Vasopressins | 2006 |
Vaptans and the treatment of water-retaining disorders.
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Humans; Hyponatremia; Tolvaptan; Vasopressins; Water | 2006 |
Vasopressin antagonists as aquaretic agents for the treatment of hyponatremia.
Topics: Antidiuretic Hormone Receptor Antagonists; Azepines; Benzamides; Benzazepines; Humans; Hyponatremia; Inappropriate ADH Syndrome; Morpholines; Pyrroles; Randomized Controlled Trials as Topic; Spiro Compounds; Tolvaptan; Vasopressins | 2006 |
AVP receptor antagonists as aquaretics: review and assessment of clinical data.
Topics: Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Azepines; Benzamides; Benzazepines; Humans; Hyponatremia; Pyrroles; Receptors, Vasopressin; Tolvaptan; Water-Electrolyte Balance | 2006 |
Evaluation and management of hyponatremia: an emerging role for vasopressin receptor antagonists.
Topics: Acute Disease; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Chronic Disease; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Hyponatremia; Male; Prognosis; Receptors, Vasopressin; Risk Assessment; Severity of Illness Index; Tolvaptan; Treatment Outcome; Water-Electrolyte Imbalance | 2007 |
Therapeutic potential of vasopressin receptor antagonists.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Azepines; Benzamides; Benzazepines; Heart Failure; Humans; Hyponatremia; Inappropriate ADH Syndrome; Liver Cirrhosis; Morpholines; Pyrroles; Receptors, Vasopressin; Spiro Compounds; Tolvaptan | 2007 |
Aquaretic agents: what's beyond the treatment of hyponatremia?
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Diuresis; Diuretics; Heart Failure; Humans; Hyponatremia; Osmolar Concentration; Polycystic Kidney Diseases; Tolvaptan | 2007 |
Tolvaptan, an orally active vasopressin V(2)-receptor antagonist - pharmacology and clinical trials.
Topics: Administration, Oral; Animals; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Disease Models, Animal; Diuresis; Diuretics; Dogs; Dose-Response Relationship, Drug; Heart Failure; Humans; Hyponatremia; Polycystic Kidney Diseases; Rats; Receptors, Vasopressin; Tolvaptan; Treatment Outcome | 2007 |
Recognition and treatment of hyponatremia in acutely ill hospitalized patients.
Topics: Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Azepines; Benzamides; Benzazepines; Critical Illness; Humans; Hyponatremia; Inpatients; Practice Guidelines as Topic; Pyrroles; Randomized Controlled Trials as Topic; Tolvaptan | 2007 |
[Vasopressin V2-receptor antagonist, tolvaptan, for treatment of heart failure].
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Body Fluids; Clinical Trials as Topic; Diuresis; Heart Failure; Humans; Hyponatremia; Tolvaptan | 2007 |
Effects of tolvaptan, an oral vasopressin V2 receptor antagonist, in hyponatremia.
Topics: Administration, Oral; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Humans; Hyponatremia; Randomized Controlled Trials as Topic; Receptors, Vasopressin; Tolvaptan | 2007 |
Hyponatremia and vasopressin antagonism in congestive heart failure.
Topics: Arginine Vasopressin; Azepines; Benzamides; Benzazepines; Chronic Disease; Clinical Trials as Topic; Diuretics; Heart Failure; Humans; Hyponatremia; Models, Biological; Pyrroles; Registries; Renin-Angiotensin System; Sodium; Tolvaptan; Treatment Outcome; Vasopressins | 2007 |
Current issues for nurse practitioners: Hyponatremia.
Topics: Aged; Algorithms; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Azepines; Benzamides; Benzazepines; Causality; Decision Trees; Diagnosis, Differential; Early Diagnosis; Female; Homeostasis; Humans; Hyponatremia; Nurse Practitioners; Nurse's Role; Nursing Assessment; Patient Selection; Primary Health Care; Pyrroles; Tolvaptan; Water-Electrolyte Balance | 2007 |
[Vasopressin antagonists in treatment of hyponatremia].
Topics: Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Heart Failure; Hormone Antagonists; Humans; Hyponatremia; Inappropriate ADH Syndrome; Liver Cirrhosis; Sodium Chloride; Tolvaptan; Water-Electrolyte Balance | 2007 |
Vasopressin-receptor antagonists in heart failure.
Topics: Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Azepines; Benzamides; Benzazepines; Cardiovascular Agents; Chronic Disease; Heart Failure; Humans; Hyponatremia; Pyrroles; Receptors, Vasopressin; Tolvaptan | 2008 |
31 trial(s) available for tolvaptan and Hyponatremia
| Article | Year |
|---|---|
Tolvaptan versus fluid restriction in acutely hospitalised patients with moderate-profound hyponatraemia (TVFR-HypoNa): design and implementation of an open-label randomised trial.
Topics: Antidiuretic Hormone Receptor Antagonists; Glucose; Humans; Hyponatremia; Postural Balance; Sodium; Time and Motion Studies; Tolvaptan | 2022 |
Tolvaptan vs. furosemide-based diuretic regimens in patients hospitalized for heart failure with hyponatremia (AQUA-AHF).
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Diuretics; Furosemide; Heart Failure; Humans; Hyponatremia; Prospective Studies; Tolvaptan | 2020 |
Open-label, multicenter, dose-titration study to determine the efficacy and safety of tolvaptan in Japanese patients with hyponatremia secondary to syndrome of inappropriate secretion of antidiuretic hormone.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Dose-Response Relationship, Drug; Female; Humans; Hyponatremia; Inappropriate ADH Syndrome; Japan; Male; Middle Aged; Tolvaptan; Treatment Outcome; Vasopressins; Young Adult | 2021 |
Early treatment with tolvaptan improves diuretic response in acute heart failure with renal dysfunction.
Topics: Acute Disease; Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Diuresis; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Glomerular Filtration Rate; Heart Failure; Humans; Hyponatremia; Injections, Intravenous; Male; Renal Insufficiency; Retrospective Studies; Time Factors; Tolvaptan; Treatment Outcome | 2017 |
Prognostic importance of sodium level trajectory in acute heart failure.
Topics: Acute Disease; Aged; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Biomarkers; Cause of Death; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Heart Failure; Hospital Mortality; Humans; Hyponatremia; Japan; Male; Prognosis; Retrospective Studies; Sodium; Survival Rate; Time Factors; Tolvaptan | 2017 |
Mechanisms of Diuresis for Acute Decompensated Heart Failure by Tolvaptan.
Topics: Acute Disease; Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Creatinine; Disease Progression; Dose-Response Relationship, Drug; Double-Blind Method; Electric Impedance; Female; Follow-Up Studies; Heart Failure; Humans; Hyponatremia; Male; Middle Aged; Prognosis; Renal Insufficiency; Retrospective Studies; Tolvaptan | 2017 |
Low-dose tolvaptan PK/PD: comparison of patients with hyponatremia due to syndrome of inappropriate antidiuretic hormone secretion to healthy adults.
Topics: Adult; Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Creatinine; Cross-Over Studies; Double-Blind Method; Female; Healthy Volunteers; Humans; Hyponatremia; Inappropriate ADH Syndrome; Male; Middle Aged; Potassium; Sodium; Tolvaptan | 2017 |
Effects of Tolvaptan Addition to Furosemide in Normo- and Hyponatremia Patients with Heart Failure and Chronic Kidney Disease Stages G3b-5: A Subanalysis of the K-STAR Study.
Topics: Administration, Oral; Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Furosemide; Heart Failure; Humans; Hyponatremia; Kidney Failure, Chronic; Male; Potassium; Prospective Studies; Sodium; Sodium Potassium Chloride Symporter Inhibitors; Tolvaptan; Treatment Outcome | 2017 |
Tolvaptan treatment improves survival of cirrhotic patients with ascites and hyponatremia.
Topics: Adult; Antidiuretic Hormone Receptor Antagonists; Ascites; Benzazepines; Double-Blind Method; Female; Humans; Hyponatremia; Liver Cirrhosis; Male; Middle Aged; Prospective Studies; Sodium; Survival Rate; Tolvaptan | 2018 |
Clinical course of patients with hyponatremia and decompensated systolic heart failure and the effect of vasopressin receptor antagonism with tolvaptan.
Topics: Aged; Analysis of Variance; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Diuretics; Dyspnea; Female; Furosemide; Heart Failure, Systolic; Humans; Hyponatremia; Male; Middle Aged; Proportional Hazards Models; Tolvaptan; Weight Loss | 2013 |
Population pharmacokinetics of tolvaptan in healthy subjects and patients with hyponatremia secondary to congestive heart failure or hepatic cirrhosis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Cross-Over Studies; Double-Blind Method; Female; Heart Failure; Humans; Hyponatremia; Liver Cirrhosis; Male; Middle Aged; Models, Biological; Tolvaptan; Young Adult | 2013 |
A rapid and efficient way to manage hyponatremia in patients with SIADH and small cell lung cancer: treatment with tolvaptan.
Topics: Aged; Algorithms; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Female; Humans; Hyponatremia; Inappropriate ADH Syndrome; Lung Neoplasms; Male; Middle Aged; Small Cell Lung Carcinoma; Sodium; Tolvaptan | 2013 |
Tolvaptan in hospitalized cancer patients with hyponatremia: a double-blind, randomized, placebo-controlled clinical trial on efficacy and safety.
Topics: Adult; Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Female; Humans; Hyponatremia; Male; Medication Adherence; Middle Aged; Neoplasms; Sodium; Time Factors; Tolvaptan; Treatment Outcome | 2014 |
Randomized, double blinded, placebo-controlled trial to evaluate the efficacy and safety of tolvaptan in Chinese patients with hyponatremia caused by SIADH.
Topics: Adult; Aged; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Double-Blind Method; Female; Humans; Hyponatremia; Inappropriate ADH Syndrome; Male; Middle Aged; Sodium; Tolvaptan; Treatment Outcome; Young Adult | 2014 |
Correction of hyponatraemia improves cognition, quality of life, and brain oedema in cirrhosis.
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Brain Edema; Cognition; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Hyponatremia; Liver Cirrhosis; Magnetic Resonance Imaging; Male; Middle Aged; Quality of Life; Sodium; Tolvaptan; Treatment Outcome | 2015 |
Can serum albumin level affect the pharmacological action of tolvaptan in patients with liver cirrhosis? A post hoc analysis of previous clinical trials in Japan.
Topics: Aged; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Female; Humans; Hyponatremia; Japan; Liver Cirrhosis; Male; Risk Assessment; Serum Albumin; Survival Rate; Tolvaptan | 2015 |
Short-Term Tolvaptan Increases Water Intake and Effectively Decreases Urinary Calcium Oxalate, Calcium Phosphate and Uric Acid Supersaturations.
Topics: Adolescent; Adult; Aged; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Biomarkers; Calcium Oxalate; Calcium Phosphates; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Drinking; Female; Follow-Up Studies; Humans; Hyponatremia; Kidney Calculi; Male; Middle Aged; Retrospective Studies; Time Factors; Tolvaptan; Treatment Outcome; Uric Acid; Young Adult | 2016 |
Tolvaptan and Neurocognitive Function in Mild to Moderate Chronic Hyponatremia: A Randomized Trial (INSIGHT).
Topics: Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Chronic Disease; Cognitive Dysfunction; Double-Blind Method; Female; Humans; Hyponatremia; Male; Middle Aged; Pilot Projects; Severity of Illness Index; Tolvaptan | 2016 |
Effect of tolvaptan on acute heart failure with hyponatremia--a randomized, double blind, controlled clinical trial.
Topics: Acute Disease; Administration, Oral; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Double-Blind Method; Female; Follow-Up Studies; Heart Failure; Humans; Hyponatremia; Male; Middle Aged; Sodium; Tolvaptan; Treatment Outcome | 2016 |
Tolvaptan use in cancer patients with hyponatremia due to the syndrome of inappropriate antidiuretic hormone: a post hoc analysis of the SALT-1 and SALT-2 trials.
Topics: Administration, Oral; Aged; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Double-Blind Method; Female; Humans; Hyponatremia; Inappropriate ADH Syndrome; Male; Middle Aged; Neoplasms; Sodium; Tolvaptan; Treatment Outcome | 2017 |
Double-blind, placebo-controlled, multicenter trial of a vasopressin V2-receptor antagonist in patients with schizophrenia and hyponatremia.
Topics: Adult; Analysis of Variance; Antidiuretic Hormone Receptor Antagonists; Area Under Curve; Benzazepines; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Hyponatremia; Male; Middle Aged; Schizophrenia; Time Factors; Tolvaptan | 2008 |
Oral tolvaptan is safe and effective in chronic hyponatremia.
Topics: Administration, Oral; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Chronic Disease; Female; Humans; Hyponatremia; Male; Middle Aged; Tolvaptan | 2010 |
Effect of serum sodium concentration and tolvaptan treatment on length of hospitalization in patients with heart failure.
Topics: Adolescent; Adult; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Cardiotonic Agents; Heart Failure; Humans; Hyponatremia; Length of Stay; Sodium; Tolvaptan | 2011 |
Tolvaptan, an oral vasopressin antagonist, in the treatment of hyponatremia in cirrhosis.
Topics: Administration, Oral; Antidiuretic Hormone Receptor Antagonists; Ascites; Benzazepines; Chronic Disease; Female; Health Surveys; Humans; Hyponatremia; Liver Cirrhosis; Male; Middle Aged; Prospective Studies; Recurrence; Sodium; Tolvaptan; Treatment Outcome | 2012 |
[The efficacy and safety of tolvaptan on treating heart failure patients with hyponatremia].
Topics: Aged; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Blood Pressure; Body Weight; Double-Blind Method; Heart Failure; Humans; Hyponatremia; Sodium; Tolvaptan | 2011 |
Efficacy and tolerance of urea compared with vaptans for long-term treatment of patients with SIADH.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Female; Humans; Hyponatremia; Inappropriate ADH Syndrome; Male; Middle Aged; Morpholines; Sodium; Spiro Compounds; Time Factors; Tolvaptan; Urea | 2012 |
Vaptans: a potential new approach for treating chronic hyponatremia in psychotic patients.
Topics: Administration, Oral; Adult; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Chronic Disease; Dose-Response Relationship, Drug; Drug-Related Side Effects and Adverse Reactions; Humans; Hyponatremia; Long-Term Care; Male; Middle Aged; Psychotic Disorders; Sodium; Tolvaptan; Treatment Outcome | 2012 |
Vasopressin V2-receptor blockade with tolvaptan in patients with chronic heart failure: results from a double-blind, randomized trial.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Body Weight; Chronic Disease; Diuretics; Double-Blind Method; Edema, Cardiac; Female; Furosemide; Heart Failure; Humans; Hyponatremia; Male; Middle Aged; Osmolar Concentration; Sodium; Tolvaptan; Treatment Outcome; Urinalysis; Water-Electrolyte Balance | 2003 |
Vasopressin v(2) receptor blockade with tolvaptan versus fluid restriction in the treatment of hyponatremia.
Topics: Aged; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Female; Fluid Therapy; Follow-Up Studies; Humans; Hyponatremia; Male; Middle Aged; Potassium; Prospective Studies; Sodium; Tolvaptan; Treatment Outcome | 2006 |
Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Area Under Curve; Benzazepines; Double-Blind Method; Female; Heart Failure; Humans; Hyponatremia; Inappropriate ADH Syndrome; Liver Cirrhosis; Male; Middle Aged; Sodium; Tolvaptan | 2006 |
Improvement in hyponatremia during hospitalization for worsening heart failure is associated with improved outcomes: insights from the Acute and Chronic Therapeutic Impact of a Vasopressin Antagonist in Chronic Heart Failure (ACTIV in CHF) trial.
Topics: Aged; Benzazepines; Female; Heart Failure; Humans; Hyponatremia; Male; Middle Aged; Receptors, Vasopressin; Retrospective Studies; Sodium; Survival Rate; Tolvaptan; Treatment Outcome | 2007 |
130 other study(ies) available for tolvaptan and Hyponatremia
| Article | Year |
|---|---|
Using Tolvaptan to Treat Hyponatremia: Results from a Post-authorization Pharmacovigilance Study.
Topics: Aged; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Humans; Hyponatremia; Inappropriate ADH Syndrome; Pharmacovigilance; Prospective Studies; Sodium; Tolvaptan | 2021 |
[Hyponatraemia in elderly patient - significance, clarification and therapy].
Topics: Aged; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Humans; Hyponatremia; Inappropriate ADH Syndrome; Tolvaptan | 2022 |
Survival analysis in cancer patients with hyponatremia: effectiveness of tolvaptan treatment.
Topics: Antidiuretic Hormone Receptor Antagonists; Humans; Hyponatremia; Neoplasms; Survival Analysis; Tolvaptan; Treatment Outcome | 2022 |
Regional Variance of the Early Use of Tolvaptan for Autosomal Dominant Polycystic Kidney Disease.
Topics: Antidiuretic Hormone Receptor Antagonists; Ascites; Humans; Hyponatremia; Polycystic Kidney, Autosomal Dominant; Tolvaptan | 2020 |
The V
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Cell Proliferation; Humans; Hyponatremia; Neoplasms; rho-Associated Kinases; Sodium; Tolvaptan | 2022 |
Tolvaptan in portal hypertension: real life experience.
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Humans; Hypertension, Portal; Hyponatremia; Retrospective Studies; Tolvaptan | 2023 |
Human herpesvirus 6 (HHV-6) associated permanent hyponatremia in umbilical cord blood transplant recipient.
Topics: Cord Blood Stem Cell Transplantation; Female; Foscarnet; Herpesvirus 6, Human; Humans; Hyponatremia; Inappropriate ADH Syndrome; Middle Aged; Roseolovirus Infections; Tolvaptan; Transplant Recipients; Viremia | 2023 |
Consensus document on the management of hyponatraemia of the Acqua Group of the Spanish Society of Endocrinology and Nutrition.
Topics: Consensus; Humans; Hyponatremia; Inappropriate ADH Syndrome; Saline Solution, Hypertonic; Tolvaptan | 2023 |
Tolvaptan resistance is related with a short-term poor prognosis in patients with lung cancer and syndrome of inappropriate anti-diuresis.
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Humans; Hyponatremia; Inappropriate ADH Syndrome; Lung Neoplasms; Neoplasm Recurrence, Local; Prognosis; Tolvaptan | 2023 |
Syndrome of inappropriate secretion of anti-diuretic hormone due to hypothalamic hamartoma: use of tolvaptan.
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Diuretics; Humans; Hyponatremia; Inappropriate ADH Syndrome; Seizures; Tolvaptan; Vasopressins | 2023 |
Relapsing Syndrome of Inappropriate Antidiuretic Hormone Production Responding to Tolvaptan Treatment in a Patient With a Micronodular Formation of the Posterior Pituitary Gland.
Topics: Adult; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Humans; Hyponatremia; Inappropriate ADH Syndrome; Male; Pituitary Gland, Posterior; Tolvaptan; Vasopressins | 2023 |
Long-term low-dose tolvaptan efficacy and safety in SIADH.
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Humans; Hyponatremia; Inappropriate ADH Syndrome; Retrospective Studies; Sodium; Tolvaptan | 2023 |
Effect of tolvaptan on hyponatremia in a dog with syndrome of inappropriate secretion of antidiuretic hormone.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Dog Diseases; Dogs; Female; Humans; Hyponatremia; Inappropriate ADH Syndrome; Sodium; Tolvaptan; Vasopressins | 2023 |
Short-Term Efficacy and Safety of Tolvaptan in Patients with Left Ventricular Assist Devices.
Topics: Adult; Antidiuretic Hormone Receptor Antagonists; Female; Heart Failure; Heart-Assist Devices; Humans; Hyponatremia; Male; Middle Aged; Retrospective Studies; Tolvaptan | 2020 |
Clinical experience with Tolvaptan outpatient use. Cost and effectiveness in 9 cases.
Topics: Aged; Aged, 80 and over; Ambulatory Care; Antidiuretic Hormone Receptor Antagonists; Female; Humans; Hyponatremia; Length of Stay; Male; Retrospective Studies; Spain; Tolvaptan | 2020 |
Risk factors for sodium overcorrection in non-hypovolemic hyponatremia patients treated with tolvaptan.
Topics: Aged; Cohort Studies; Female; Humans; Hyponatremia; Inappropriate ADH Syndrome; Male; Middle Aged; Retrospective Studies; Risk Factors; Sodium; Tolvaptan | 2020 |
Tolvaptan therapy to treat severe hyponatremia in pediatric nephrotic syndrome.
Topics: Antidiuretic Hormone Receptor Antagonists; Female; Humans; Hyponatremia; Infant; Nephrotic Syndrome; Tolvaptan | 2020 |
Tolvaptan efficacy and drug-drug interactions.
Topics: Antidiuretic Hormone Receptor Antagonists; Drug Interactions; Food-Drug Interactions; Humans; Hyponatremia; Tolvaptan | 2020 |
[Hyponatremia in older persons (II)-A clear treatment : How to detect tricks and avoid pitfalls].
Topics: Aged; Aged, 80 and over; Algorithms; Antidiuretic Hormone Receptor Antagonists; Combined Modality Therapy; Fluid Therapy; Humans; Hyponatremia; Inappropriate ADH Syndrome; Infusions, Intravenous; Saline Solution, Hypertonic; Tolvaptan; Treatment Outcome | 2020 |
Tolvaptan treatment in hyponatremia due to the syndrome of inappropriate secretion of antidiuretic hormone (SIADH): effects on survival in patients with cancer.
Topics: Adult; Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Female; Humans; Hyponatremia; Inappropriate ADH Syndrome; Male; Middle Aged; Neoplasms; Retrospective Studies; Survival Rate; Tolvaptan | 2021 |
Protective effect of tolvaptan against cyclophosphamide-induced nephrotoxicity in rat models.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Antineoplastic Agents; Apoptosis; Cyclophosphamide; Cytokines; Heart Failure; Hyponatremia; Injections, Intraperitoneal; Kidney Function Tests; Lipid Peroxidation; Liver Cirrhosis; Male; Models, Animal; Oxidative Stress; Protective Agents; Rats; Receptors, Vasopressin; Renal Insufficiency; Tolvaptan | 2020 |
Real-World, Non-Interventional, Retrospective Study (SAMPLE) of Tolvaptan in Patients with Hyponatraemia Secondary to the Syndrome of Inappropriate Antidiuretic Hormone Secretion.
Topics: Adult; Aged; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Germany; Humans; Hyponatremia; Inappropriate ADH Syndrome; Retrospective Studies; Spain; Tolvaptan; Vasopressins | 2021 |
A metabolically stable apelin-17 analog decreases AVP-induced antidiuresis and improves hyponatremia.
Topics: Amino Acid Sequence; Animals; Apelin; Apelin Receptors; Arginine Vasopressin; Blood Glucose; Blood Pressure; Cell Line; Colforsin; Cyclic AMP; Deamino Arginine Vasopressin; Disease Models, Animal; Diuresis; Electrolytes; Half-Life; Hyponatremia; Kidney Tubules, Collecting; Male; Mice; Models, Biological; Myocardial Contraction; Peptides; Phosphorylation; Rats, Sprague-Dawley; Tolvaptan | 2021 |
Clinical Experience of the Efficacy and Safety of Low-dose Tolvaptan Therapy in a UK Tertiary Oncology Setting.
Topics: Aged; Antidiuretic Hormone Receptor Antagonists; Female; Follow-Up Studies; Humans; Hyponatremia; Male; Neoplasms; Prognosis; Retrospective Studies; Tolvaptan | 2021 |
Efficacy of oral tolvaptan for severe edema and hyponatremia in a patient with refractory nephrotic syndrome.
Topics: Antidiuretic Hormone Receptor Antagonists; Child; Edema; Humans; Hyponatremia; Male; Nephrotic Syndrome; Tolvaptan | 2021 |
Acute hyponatremia after aneurysmal subarachnoid hemorrhage: Frequency, treatment, and outcome.
Topics: Adult; Aged; Antidiuretic Hormone Receptor Antagonists; Germany; Glasgow Outcome Scale; Humans; Hyponatremia; Male; Middle Aged; Retrospective Studies; Subarachnoid Hemorrhage; Tolvaptan; Treatment Outcome | 2021 |
Prediction of diuretic response to tolvaptan by a simple, readily available spot urine Na/K ratio.
Topics: Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Ascites; Benzazepines; Body Weight; Diuretics; Female; Humans; Hyponatremia; Liver Cirrhosis; Male; Middle Aged; Multivariate Analysis; Potassium; Sodium; Tolvaptan; Treatment Outcome; Weight Loss | 2017 |
An economic analysis of tolvaptan compared with fluid restriction among hospitalized patients with hyponatremia.
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Decision Support Techniques; Fluid Therapy; Heart Failure; Hospitalization; Humans; Hyponatremia; Inappropriate ADH Syndrome; Intensive Care Units; Length of Stay; Models, Econometric; Patient Readmission; Severity of Illness Index; Sodium; Tolvaptan | 2017 |
Use of tolvaptan in patients hospitalized for worsening chronic heart failure with severe hyponatremia: The initial experience at a single-center in Turkey.
Topics: Aged; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Cohort Studies; Female; Heart Failure; Humans; Hyponatremia; Male; Middle Aged; Retrospective Studies; Tolvaptan; Turkey | 2017 |
Efficacy and safety of the early use of V2 receptor antagonists in elderly patients with decompensated heart failure.
Topics: Age Factors; Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Female; Follow-Up Studies; Heart Failure; Humans; Hyponatremia; Japan; Male; Middle Aged; Retrospective Studies; Risk Factors; Survival Rate; Time Factors; Tolvaptan; Treatment Outcome | 2018 |
The Outcome of Cirrhotic Patients with Ascites Is Improved by the Normalization of the Serum Sodium Level by Tolvaptan.
Topics: Aged; Antidiuretic Hormone Receptor Antagonists; Ascites; Benzazepines; Female; Humans; Hyponatremia; Japan; Liver Cirrhosis; Male; Middle Aged; Prognosis; Retrospective Studies; Sodium; Tolvaptan; Treatment Outcome | 2017 |
[Hyponatremia in a 58-year-old female patient with EGFR-positive lung adenocarcinoma].
Topics: Adenocarcinoma of Lung; Afatinib; Biopsy; Bronchoscopy; Cell Transformation, Neoplastic; Disease Progression; DNA Mutational Analysis; DNA-Binding Proteins; ErbB Receptors; Female; Humans; Hyponatremia; Lung; Lung Neoplasms; Middle Aged; Neoplasm Staging; Neoplasms, Second Primary; Paraneoplastic Syndromes; Small Cell Lung Carcinoma; Tolvaptan; Tomography, X-Ray Computed; Transcription Factors | 2018 |
Amiodarone-Induced Hyponatremia Masked by Tolvaptan in a Patient with an Implantable Left Ventricular Assist Device.
Topics: Adult; Amiodarone; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Delirium; Heart Failure; Heart-Assist Devices; Humans; Hyponatremia; Inappropriate ADH Syndrome; Male; Sodium Channel Blockers; Tolvaptan | 2017 |
Utility of Tolvaptan in the Perioperative Management of Severe Hyponatremia During Liver Transplantation: A Case Report.
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Humans; Hyponatremia; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Preoperative Care; Tolvaptan | 2017 |
Utilization and budget impact of tolvaptan in the inpatient setting among patients with heart failure and hyponatremia.
Topics: Aged; Antidiuretic Hormone Receptor Antagonists; Budgets; Databases, Factual; Female; Heart Failure; Hospital Costs; Hospitalization; Humans; Hyponatremia; Inpatients; Male; Middle Aged; Tolvaptan | 2018 |
Tolvaptan Improves Prognosis in Responders with Acute Decompensated Heart Failure by Reducing the Dose of Loop Diuretics.
Topics: Aged; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Disease-Free Survival; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Glomerular Filtration Rate; Heart Failure; Humans; Hyponatremia; Japan; Male; Prognosis; Propensity Score; Retrospective Studies; Sodium Potassium Chloride Symporter Inhibitors; Survival Rate; Tolvaptan | 2018 |
Long-term low-dose tolvaptan treatment in hospitalized male patients aged >90 years with hyponatremia: Report on safety and effectiveness.
Topics: Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Body Weight; Chlorine; Dose-Response Relationship, Drug; Hospitalization; Humans; Hyponatremia; Male; Retrospective Studies; Sodium; Time Factors; Tolvaptan | 2017 |
Rapidity of Correction of Hyponatremia Due to Syndrome of Inappropriate Secretion of Antidiuretic Hormone Following Tolvaptan.
Topics: Adult; Aged; Antidiuretic Hormone Receptor Antagonists; Cohort Studies; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Heart Failure; Humans; Hyponatremia; Inappropriate ADH Syndrome; Linear Models; Male; Middle Aged; Multivariate Analysis; Retrospective Studies; Severity of Illness Index; Sodium; Tolvaptan; Treatment Outcome | 2018 |
Guillain-Barré syndrome and hyponatraemia.
Topics: Antidiuretic Hormone Receptor Antagonists; Guillain-Barre Syndrome; Humans; Hyponatremia; Male; Middle Aged; Muscle Weakness; Spain; Tolvaptan | 2020 |
Association between the Serum Sodium Levels and the Response to Tolvaptan in Liver Cirrhosis Patients with Ascites and Hyponatremia.
Topics: Antidiuretic Hormone Receptor Antagonists; Ascites; Benzazepines; Female; Humans; Hyponatremia; Liver Cirrhosis; Male; Middle Aged; Prognosis; Retrospective Studies; Sodium; Tolvaptan; Treatment Outcome | 2018 |
Safety and Efficacy of Tolvaptan in Korean Patients with Hyponatremia Caused by the Syndrome of Inappropriate Antidiuretic Hormone.
Topics: Adult; Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Asian People; Benzazepines; Body Mass Index; Body Weight; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Hyponatremia; Inappropriate ADH Syndrome; Male; Middle Aged; Republic of Korea; Sodium; Tolvaptan; Treatment Outcome; Young Adult | 2018 |
Tolvaptan rescue contrast-induced acute kidney injury: A case report.
Topics: Acute Kidney Injury; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Contrast Media; Coronary Artery Disease; Female; Humans; Hyponatremia; Middle Aged; Oliguria; Percutaneous Coronary Intervention; Tolvaptan | 2018 |
Tolvaptan for the Syndrome of Inappropriate Secretion of Antidiuretic Hormone: Is the Dose Too High?
Topics: Antidiuretic Hormone Receptor Antagonists; Humans; Hyponatremia; Inappropriate ADH Syndrome; Tolvaptan; Vasopressins | 2018 |
SIADH with Severe Hyponatremia in an Elderly Man with Herpes Zoster Infection: A Causal or Casual Association?
Topics: Aged; Antidiuretic Hormone Receptor Antagonists; Herpes Zoster; Humans; Hyponatremia; Inappropriate ADH Syndrome; Male; Saline Solution, Hypertonic; Tolvaptan | 2018 |
Economic impact of tolvaptan treatment vs. fluid restriction based on real-world data among hospitalized patients with heart failure and hyponatremia.
Topics: Aged; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Female; Fluid Therapy; Heart Failure; Humans; Hyponatremia; Length of Stay; Male; Middle Aged; Models, Economic; Tolvaptan | 2018 |
Efficiency of Single Dose of Tolvaptan Treatment During the Triphasic Episode After Surgery for Craniopharyngioma
Topics: Adolescent; Antidiuretic Hormone Receptor Antagonists; Craniopharyngioma; Female; Humans; Hyponatremia; Inappropriate ADH Syndrome; Neurosurgical Procedures; Pituitary Neoplasms; Postoperative Complications; Prognosis; Tolvaptan | 2019 |
Management Strategies and Outcomes for Hyponatremia in Cirrhosis in the Hyponatremia Registry.
Topics: Aged; Antidiuretic Agents; Female; Fluid Therapy; Hospitalization; Humans; Hyponatremia; Isotonic Solutions; Liver Cirrhosis; Male; Middle Aged; Recurrence; Registries; Sodium; Tolvaptan; Treatment Outcome | 2018 |
Tolvaptan corrects hyponatremia and relieves the burden of fluid/dietary restriction and hospitalization in hyponatremic patients with terminal lung cancer: a report of two cases.
Topics: Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Hospitalization; Humans; Hyponatremia; Inappropriate ADH Syndrome; Male; Middle Aged; Patient Discharge; Quality of Life; Small Cell Lung Carcinoma; Tolvaptan; Treatment Outcome | 2019 |
Efficacy and Safety of Oral Tolvaptan Therapy in Hospitalized Cirrhotic Patients with Hyponatremia.
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Humans; Hyponatremia; Liver Cirrhosis; Prospective Studies; Tolvaptan | 2018 |
Successful conversion from thiazide to tolvaptan in a patient with stage d heart failure and chronic kidney disease before heart transplantation.
Topics: Benzazepines; Dose-Response Relationship, Drug; Drug Substitution; Heart Failure; Heart Transplantation; Humans; Hyponatremia; Kidney Function Tests; Male; Middle Aged; Postoperative Complications; Preoperative Care; Renal Agents; Renal Insufficiency, Chronic; Severity of Illness Index; Stroke Volume; Time; Tolvaptan; Treatment Outcome; Trichlormethiazide | 2013 |
Tolvaptan increases serum sodium in pediatric patients with heart failure.
Topics: Adolescent; Benzazepines; Blood Pressure; Child; Child, Preschool; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Heart Failure; Humans; Hyponatremia; Infant; Infant, Newborn; Male; Retrospective Studies; Sodium; Tolvaptan; Treatment Outcome | 2013 |
Tolvaptan for the treatment of hyponatremia and hypervolemia in patients with congestive heart failure.
Topics: Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Blood Volume; Dose-Response Relationship, Drug; Heart Failure; Homeostasis; Humans; Hyponatremia; Kidney; Sodium; Tolvaptan; Treatment Outcome | 2013 |
Juxtaglomerular cell tumor: multicentric synchronous disease associated with paraneoplastic syndrome.
Topics: Antidiuretic Hormone Receptor Antagonists; Antineoplastic Combined Chemotherapy Protocols; Benzazepines; Dacarbazine; Deoxycytidine; Diagnosis, Differential; Disease Progression; Doxorubicin; Gemcitabine; Humans; Hyponatremia; Ifosfamide; Immunohistochemistry; Immunophenotyping; Inappropriate ADH Syndrome; Juxtaglomerular Apparatus; Kidney Neoplasms; Luminescent Measurements; Male; Middle Aged; Neoplasms, Multiple Primary; Paclitaxel; Paraneoplastic Syndromes; Renin; Tolvaptan; Vinblastine; Vinorelbine | 2013 |
[Severe hyponatremia secondary to the syndrome of inappropriate secretion of antidiuretic hormone].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Brain Injuries; Confusion; Humans; Hyponatremia; Inappropriate ADH Syndrome; Kidney; Male; Middle Aged; Multiple Trauma; Paraventricular Hypothalamic Nucleus; Psychomotor Agitation; Rhabdomyolysis; Saline Solution, Hypertonic; Supraoptic Nucleus; Tolvaptan | 2013 |
Reconsidering chronic hyponatremia in psychosis.
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Chronic Disease; Diagnosis, Differential; Humans; Hyponatremia; Natriuretic Agents; Patient Selection; Psychotic Disorders; Severity of Illness Index; Sodium; Tolvaptan; Treatment Outcome; Water-Electrolyte Balance | 2013 |
Hyponatremia in heart failure: time for a trial.
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Clinical Trials as Topic; Heart Failure; Humans; Hyponatremia; Sodium Potassium Chloride Symporter Inhibitors; Tolvaptan | 2013 |
Use of oral vasopressin V2 receptor antagonist for hyponatremia in acute brain injury.
Topics: Adult; Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Brain Injuries; Female; Humans; Hyponatremia; Male; Middle Aged; Tolvaptan | 2013 |
Factors predicting postoperative hyponatremia and efficacy of hyponatremia management strategies after more than 1000 pituitary operations.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Child; Child, Preschool; Female; Humans; Hyponatremia; Hypopituitarism; Inappropriate ADH Syndrome; Male; Middle Aged; Neurosurgical Procedures; Pituitary Gland; Postoperative Complications; Retrospective Studies; Sodium; Tolvaptan; Treatment Outcome; Young Adult | 2013 |
[The treament of hyponatremia secundary to the syndrome of inappropriate antidiuretic hormone secretion].
Topics: Acute Disease; Algorithms; Benzazepines; Combined Modality Therapy; Decision Support Techniques; Fluid Therapy; Furosemide; Humans; Hyponatremia; Inappropriate ADH Syndrome; Infusions, Intravenous; Saline Solution, Hypertonic; Severity of Illness Index; Tolvaptan | 2013 |
Urine sodium excretion after tolvaptan administration is dependent upon baseline serum sodium levels: a possible explanation for the improvement of hyponatremia with scarce chance of hypernatremia by a vasopressin receptor antagonist.
Topics: Adult; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Diuretics; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Heart Failure; Humans; Hypernatremia; Hyponatremia; Male; Middle Aged; Retrospective Studies; Sodium; Tolvaptan; Treatment Outcome | 2014 |
Management of hyponatremia in clinical hepatology practice.
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Drinking Behavior; Fluid Therapy; Humans; Hyponatremia; Liver Cirrhosis; Morpholines; Spiro Compounds; Tolvaptan | 2014 |
Prompt efficacy of tolvaptan in treating hyponatremia of syndrome of inappropriate secretion of antidiuretic hormone (SIADH) closely associated with rupture of a gastric artery aneurysm.
Topics: Abdominal Pain; Aged; Aneurysm; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Brain; Humans; Hyponatremia; Inappropriate ADH Syndrome; Magnetic Resonance Imaging; Male; Osmolar Concentration; Stomach; Tolvaptan | 2014 |
Minocycline prevents osmotic demyelination associated with aquaresis.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Aquaporin 4; Astrocytes; Behavior, Animal; Benzazepines; Biomarkers; Brain; Chemokines; Cytokines; Cytoprotection; Deamino Arginine Vasopressin; Demyelinating Diseases; Disease Models, Animal; Diuresis; Hyponatremia; Intracranial Hemorrhages; Male; Matrix Metalloproteinases; Minocycline; Neuroprotective Agents; Osmosis; Rats, Sprague-Dawley; Saline Solution, Hypertonic; Sodium; Therapeutics; Time Factors; Tolvaptan; Water-Electrolyte Balance | 2014 |
Use of tolvaptan in patients with hyponatremia due to heart failure: initial experience.
Topics: Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Female; Heart Failure; Humans; Hyponatremia; Male; Middle Aged; Tolvaptan | 2013 |
Efficacy of tolvaptan in patients hospitalized for heart failure with refractory hyponatremia. Clinical experience in daily practice.
Topics: Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Drug Resistance; Female; Heart Failure; Humans; Hyponatremia; Male; Middle Aged; Retrospective Studies; Tolvaptan; Water-Electrolyte Balance | 2013 |
Treatment of hyponatremia induced by the syndrome of Inappropriate antidiuretic hormone secretion: a multidisciplinary spanish algorithm.
Topics: Algorithms; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Humans; Hyponatremia; Inappropriate ADH Syndrome; Saline Solution, Hypertonic; Tolvaptan | 2014 |
Once-weekly tolvaptan for chronic symptomatic hyponatremia due to syndrome of inappropriate secretion of anti-diuretic hormone.
Topics: Aged, 80 and over; Benzazepines; Chronic Disease; Drug Administration Schedule; Humans; Hyponatremia; Inappropriate ADH Syndrome; Male; Tolvaptan | 2014 |
Cost-effectiveness of tolvaptan for euvolemic or hypervolemic hyponatremia.
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Blood Volume; Cost-Benefit Analysis; Heart Failure; Hospitalization; Humans; Hyponatremia; Models, Economic; Probability; Quality-Adjusted Life Years; Republic of Korea; Tolvaptan | 2014 |
Clinical efficacy of tolvaptan for treatment of refractory ascites in liver cirrhosis patients.
Topics: Antidiuretic Hormone Receptor Antagonists; Ascites; Benzazepines; Biomarkers; Edema; Female; Humans; Hyponatremia; Liver Cirrhosis; Male; Middle Aged; Sodium; Time Factors; Tolvaptan; Treatment Outcome; Urination; Urodynamics | 2014 |
[Hyponatremia: differential diagnosis and therapy].
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Diagnosis, Differential; Evidence-Based Medicine; Fluid Therapy; Humans; Hyponatremia; Inappropriate ADH Syndrome; Tolvaptan | 2014 |
[Lower doses of tolvaptan in hyponatremia due to syndrome of inappropriate antidiuretic hormone secretion].
Topics: Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Hyponatremia; Inappropriate ADH Syndrome; Male; Tolvaptan; Treatment Outcome | 2015 |
Is urine concentration a reliable biomarker to guide vaptan usage in psychiatric patients with symptomatic hyponatremia?
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Biomarkers; Humans; Hyponatremia; Psychotic Disorders; Sodium; Tolvaptan | 2015 |
Current treatment practice and outcomes. Report of the hyponatremia registry.
Topics: Aged; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Female; Fluid Therapy; Humans; Hyponatremia; Male; Middle Aged; Osmolar Concentration; Registries; Saline Solution, Hypertonic; Sodium; Tolvaptan; Treatment Outcome | 2015 |
Efficacy and safety of long-term tolvaptan treatment in a patient with SCLC and SIADH.
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Chemoradiotherapy; Drug Administration Schedule; Female; Humans; Hyponatremia; Inappropriate ADH Syndrome; Lung Neoplasms; Middle Aged; Remission Induction; Small Cell Lung Carcinoma; Tolvaptan; Treatment Outcome | 2015 |
[Syndrome of inadequate ADH secretion: pitfalls in diagnosis and therapy].
Topics: Aged; Benzazepines; Female; Humans; Hyperkalemia; Hyponatremia; Inappropriate ADH Syndrome; Long-Term Care; Male; Middle Aged; Prognosis; Saline Solution, Hypertonic; Sodium; Tolvaptan; Water Deprivation | 2015 |
Effectiveness and adverse events of tolvaptan in octogenarians with heart failure. Interim analyses of Samsca Post-Marketing Surveillance In Heart faiLurE (SMILE study).
Topics: Age Factors; Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Drinking; Female; Heart Failure; Humans; Hyponatremia; Incidence; Male; Middle Aged; Product Surveillance, Postmarketing; Prospective Studies; Thirst; Tolvaptan; Treatment Outcome | 2015 |
The first case of levetiracetam-induced and tolvaptan-resistant hyponatremia.
Topics: Aged; Anticonvulsants; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Epilepsy; Heart Failure; Humans; Hyponatremia; Inappropriate ADH Syndrome; Levetiracetam; Male; Piracetam; Tolvaptan | 2015 |
[Hyponatremia and tolvaptan : what is the situation 5 years after approval?].
Topics: Benzazepines; Chemical and Drug Induced Liver Injury; Diuretics; Drug Approval; Evidence-Based Medicine; Germany; Hypernatremia; Hyponatremia; Risk Assessment; Tolvaptan; Treatment Outcome | 2015 |
The diagnosis and management of inpatient hyponatraemia and SIADH.
Topics: Algorithms; Anti-Bacterial Agents; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Demeclocycline; Fluid Therapy; Hospitalization; Humans; Hyponatremia; Inappropriate ADH Syndrome; Practice Guidelines as Topic; Tolvaptan; Water-Electrolyte Imbalance | 2015 |
[77-year-old female with hyponatremia, pruritus and papulous exanthema].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Benzazepines; Diagnosis, Differential; Disease Progression; Exanthema; Female; Humans; Hyponatremia; Inappropriate ADH Syndrome; Lymphoma, T-Cell, Cutaneous; Multimodal Imaging; Paraneoplastic Syndromes; Positron-Emission Tomography; Pruritus; Tolvaptan; Tomography, X-Ray Computed | 2015 |
Mutation in the V2 vasopressin receptor gene, AVPR2, causes nephrogenic syndrome of inappropriate diuresis.
Topics: Adult; Antidiuretic Hormone Receptor Antagonists; Arrestins; Benzazepines; beta-Arrestins; Cell Membrane; Cyclic AMP; DNA Mutational Analysis; Dynamins; Endocytosis; Exons; Female; Genetic Diseases, X-Linked; HEK293 Cells; Humans; Hyponatremia; Inappropriate ADH Syndrome; Male; Mutation; Pedigree; Receptors, Vasopressin; Tolvaptan | 2015 |
'Dos and don'ts' in the management of hyponatremia.
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Disease Management; Fluid Therapy; Humans; Hyponatremia; Inappropriate ADH Syndrome; Practice Guidelines as Topic; Saline Solution, Hypertonic; Tolvaptan; Water-Electrolyte Balance | 2015 |
Successful Treatment of Intractable Fluid Retention Using Tolvaptan After Treatment for Postoperative Mediastinitis in a Patient With a Left Ventricular Assist Device.
Topics: Adult; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Female; Heart Failure; Heart-Assist Devices; Hemodynamics; Humans; Hyponatremia; Mediastinitis; Negative-Pressure Wound Therapy; Omentum; Postoperative Complications; Prosthesis Implantation; Tissue Transplantation; Tolvaptan; Treatment Outcome | 2015 |
Real-life experience of tolvaptan use in the treatment of severe hyponatraemia due to syndrome of inappropriate antidiuretic hormone secretion.
Topics: Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Humans; Hyponatremia; Inappropriate ADH Syndrome; Inpatients; Length of Stay; Middle Aged; Retrospective Studies; Severity of Illness Index; Sodium; Time Factors; Tolvaptan; Treatment Outcome | 2016 |
SIADH-related hyponatremia in hospital day care units: clinical experience and management with tolvaptan.
Topics: Adult; Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Day Care, Medical; Female; Hospitalization; Humans; Hyponatremia; Inappropriate ADH Syndrome; Male; Middle Aged; Quality of Life; Retrospective Studies; Tolvaptan | 2016 |
Effects of tolvaptan on congestive heart failure complicated with chylothorax in a neonate.
Topics: Adult; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Body Weight; Chylothorax; Female; Heart Failure; Humans; Hyponatremia; Infant, Newborn; Male; Radiography, Thoracic; Tolvaptan; Transposition of Great Vessels | 2015 |
Short-Term, Low-Dose Use of Tolvaptan as a Bridge Therapy to Expedite Liver Transplant for Severe Hyponatremic, Cirrhotic Patients With High Model for End-Stage Liver Disease Scores.
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Decision Support Techniques; Drug Administration Schedule; Fatal Outcome; Humans; Hyponatremia; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Severity of Illness Index; Time Factors; Tolvaptan; Treatment Outcome; Waiting Lists | 2017 |
Low-dose tolvaptan for the treatment of hyponatremia in the syndrome of inappropriate ADH secretion (SIADH).
Topics: Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Female; Humans; Hyponatremia; Inappropriate ADH Syndrome; Male; Middle Aged; Tolvaptan; Treatment Outcome | 2016 |
Recovery from hyponatremia in acute phase is associated with better in-hospital mortality rate in acute heart failure syndrome.
Topics: Acute Disease; Age Factors; Aged; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Female; Heart Failure; Hospital Mortality; Humans; Hyponatremia; Male; Myocardial Ischemia; Prognosis; Retrospective Studies; Sex Factors; Tolvaptan | 2016 |
Combination of Urinary Sodium/Creatinine Ratio and Plasma Brain Natriuretic Peptide Level Predicts Successful Tolvaptan Therapy in Patients With Heart Failure and Volume Overload.
Topics: Aged; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Biomarkers; Creatinine; Diuresis; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Heart Failure; Humans; Hyponatremia; Male; Natriuretic Peptide, Brain; Prognosis; Retrospective Studies; Sodium; Tolvaptan; Ventricular Pressure | 2016 |
Cost-effectiveness of tolvaptan for the treatment of hyponatraemia secondary to syndrome of inappropriate antidiuretic hormone secretion in Sweden.
Topics: Aged; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Cost-Benefit Analysis; Female; Humans; Hyponatremia; Inappropriate ADH Syndrome; Lung Neoplasms; Male; Pneumonia; Quality-Adjusted Life Years; Sweden; Tolvaptan | 2016 |
Potential Effectiveness of Tolvaptan to Improve Ascites Unresponsive to Standard Diuretics and Overall Survival in Patients with Decompensated Liver Cirrhosis.
Topics: Aged; Ascites; Benzazepines; Carcinoma, Hepatocellular; Diuretics; Female; Humans; Hyponatremia; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Retrospective Studies; Survival Rate; Tolvaptan | 2016 |
Effect of single-dose of tolvaptan in neurocritical patients with hyponatremia due to syndrome of inappropriate antidiuretic hormone secretion.
Topics: Adult; Benzazepines; Brain Injuries, Traumatic; Cerebral Hemorrhage; Critical Care; Critical Illness; Dose-Response Relationship, Drug; Drug Evaluation; Female; Humans; Hyponatremia; Inappropriate ADH Syndrome; Male; Middle Aged; Retrospective Studies; Sodium; Subarachnoid Hemorrhage; Tolvaptan; Water-Electrolyte Balance | 2017 |
[Current options of treatment of hyponatremia].
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Europe; Heart Failure; Humans; Hyponatremia; Inappropriate ADH Syndrome; Liver Cirrhosis; Receptors, Vasopressin; Sodium; Tolvaptan; Vasopressins | 2016 |
Hyponatremia and cyst growth in neonatal polycystic kidney disease: a case for aquaretics?
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Humans; Hyponatremia; Infant; Infant, Newborn; Polycystic Kidney Diseases; Receptors, Vasopressin; Tolvaptan | 2017 |
Comparison of tolvaptan treatment between patients with the SIADH and congestive heart failure: a single-center experience.
Topics: Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Female; Heart Failure; Humans; Hyponatremia; Inappropriate ADH Syndrome; Male; Middle Aged; Retrospective Studies; Tolvaptan | 2018 |
Effectiveness and Tolerability of Conivaptan and Tolvaptan for the Treatment of Hyponatremia in Neurocritically Ill Patients.
Topics: Adult; Aged; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Cohort Studies; Critical Illness; Female; Humans; Hypokalemia; Hyponatremia; Injections, Intravenous; Male; Middle Aged; Nervous System Diseases; Retrospective Studies; Sodium; Tolvaptan; Treatment Outcome | 2017 |
Introduction: Vasopressin therapy.
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Chronic Disease; Heart Failure; Humans; Hyponatremia; Sodium; Tolvaptan; Vasopressins | 2009 |
EVEREST study: Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study with Tolvaptan.
Topics: Acute Disease; Aged; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Cardiovascular Agents; Europe; Female; Heart Failure; Hospitalization; Humans; Hyponatremia; Male; Middle Aged; North America; Randomized Controlled Trials as Topic; Tolvaptan | 2008 |
The vaptans ante portas: a status report.
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Heart Failure; Humans; Hyponatremia; Tolvaptan; Treatment Outcome; Vasopressins | 2009 |
Hyponatremia: case vignettes.
Topics: Adult; Aged; Benzazepines; Deamino Arginine Vasopressin; Female; Humans; Hyponatremia; Male; Middle Aged; Saline Solution, Hypertonic; Tolvaptan; Treatment Outcome | 2009 |
FDA approves oral vasopressin antagonist.
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Contraindications; Drug Approval; Drug Labeling; Humans; Hyponatremia; Tolvaptan; United States; United States Food and Drug Administration | 2009 |
Tolvaptan.
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Drug Approval; Drug Discovery; Humans; Hyponatremia; Randomized Controlled Trials as Topic; Tolvaptan | 2009 |
Tolvaptan and hyponatremia in a patient with cirrhosis.
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Humans; Hyponatremia; Liver Cirrhosis, Alcoholic; Male; Middle Aged; Tolvaptan | 2010 |
Treatment of chronic hyponatremia: now we know how, but do we know when or if?
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Chronic Disease; Humans; Hyponatremia; Tolvaptan | 2010 |
Chronic hyponatremia impairs memory in rats: effects of vasopressin antagonist tolvaptan.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Avoidance Learning; Benzazepines; Body Water; Brain; Deamino Arginine Vasopressin; Hyponatremia; Male; Memory; Memory Disorders; Motor Activity; Rats; Rats, Sprague-Dawley; Reaction Time; Receptors, Vasopressin; Sodium; Tolvaptan | 2010 |
Hyponatraemia: new associations and new treatments.
Topics: Benzazepines; Clinical Trials as Topic; Humans; Hyponatremia; Tolvaptan | 2010 |
New drugs for hyponatraemia.
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Humans; Hyponatremia; Technology, Pharmaceutical; Tolvaptan | 2010 |
Hyponatremia: vasopressin antagonists in hyponatremia: more data needed.
Topics: Benzazepines; Clinical Trials as Topic; Drug Resistance; Humans; Hyponatremia; Tolvaptan; Vasopressins | 2011 |
New drugs for hyponatraemia. Cost effectiveness of tolvaptan.
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Cost-Benefit Analysis; Humans; Hyponatremia; Tolvaptan | 2011 |
Serum and urine responses to the aquaretic agent tolvaptan in hospitalized hyponatremic patients.
Topics: Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Blood Pressure; Diuretics; Heart Failure; Humans; Hyponatremia; Inappropriate ADH Syndrome; Osmolar Concentration; Sodium; Tolvaptan | 2012 |
Tolvaptan.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Humans; Hyponatremia; Inappropriate ADH Syndrome; Tolvaptan | 2012 |
Massive aquaresis after tolvaptan administration and albumin infusion in a patient with alcoholic cirrhosis.
Topics: Adult; Albumins; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Humans; Hyponatremia; Infusions, Intravenous; Liver Cirrhosis, Alcoholic; Male; Polyuria; Tolvaptan | 2012 |
Evaluation of costs associated with tolvaptan-mediated length-of-stay reduction among heart failure patients with hyponatremia in the US, based on the EVEREST trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Benzazepines; Comorbidity; Costs and Cost Analysis; Databases, Factual; Heart Failure; Hospital Costs; Humans; Hyponatremia; Length of Stay; Middle Aged; Monte Carlo Method; Outcome Assessment, Health Care; Tolvaptan; United States; Young Adult | 2012 |
Evaluation of costs associated with tolvaptan-mediated hospital length of stay reduction among US patients with the syndrome of inappropriate antidiuretic hormone secretion, based on SALT-1 and SALT-2 trials.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Benzazepines; Cost Savings; Female; Health Care Costs; Hospitalization; Humans; Hyponatremia; Inappropriate ADH Syndrome; Length of Stay; Male; Middle Aged; Monte Carlo Method; Randomized Controlled Trials as Topic; Tolvaptan; United States; Young Adult | 2012 |
Considerations regarding the management of hyponatraemia secondary to SIADH.
Topics: Aged; Benzazepines; Female; Humans; Hyponatremia; Inappropriate ADH Syndrome; Male; Middle Aged; Osmolar Concentration; Saline Solution, Hypertonic; Time Factors; Tolvaptan; Treatment Outcome; Water | 2012 |
Perspectives on the management of hyponatraemia secondary to SIADH across Europe.
Topics: Antidiuretic Hormone Receptor Antagonists; Awareness; Benzazepines; Costs and Cost Analysis; Education, Medical; Europe; Humans; Hyponatremia; Inappropriate ADH Syndrome; Osmolar Concentration; Prognosis; Surveys and Questionnaires; Tolvaptan; Urine | 2012 |
[A case of venlafaxine-induced syndrome of inappropriate ADH secretion (SIADH) - treatment with tolvaptan].
Topics: Aged; Antidepressive Agents, Second-Generation; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Cyclohexanols; Depressive Disorder; Diagnosis, Differential; Epilepsy, Generalized; Female; Humans; Hyponatremia; Inappropriate ADH Syndrome; Tolvaptan; Venlafaxine Hydrochloride | 2012 |
Vasopressin receptor antagonist in the treatment of the syndrome of inappropriate antidiuretic hormone in general hospital practice.
Topics: Adult; Aged; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Female; Hormone Antagonists; Humans; Hyponatremia; Inappropriate ADH Syndrome; Male; Middle Aged; Retrospective Studies; Sodium; Tolvaptan; United Kingdom | 2012 |
Unusual case of hyponatraemia.
Topics: Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Early Diagnosis; Humans; Hydrocortisone; Hyponatremia; Male; Practice Guidelines as Topic; Prognosis; Sodium; Syncope; Tolvaptan; Vasodilator Agents | 2012 |
Hyponatremia and outcomes in patients with heart failure.
Topics: Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Disease Progression; Global Health; Heart Failure; Humans; Hyponatremia; Incidence; Prognosis; Sodium; Survival Rate; Tolvaptan | 2012 |
Correction of hyponatremia by tolvaptan before left ventricular assist device implantation.
Topics: Adult; Benzazepines; Follow-Up Studies; Heart Failure; Heart-Assist Devices; Humans; Hyponatremia; Male; Sodium; Tolvaptan | 2012 |
[Vasopressin antagonist in hyponatremia. Rapid and simple control of serum sodium concentration].
Topics: Aged; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Controlled Clinical Trials as Topic; Female; Humans; Hyponatremia; Inappropriate ADH Syndrome; Male; Sodium; Tolvaptan | 2012 |
Therapeutic effects of tolvaptan, a potent, selective nonpeptide vasopressin V2 receptor antagonist, in rats with acute and chronic severe hyponatremia.
Topics: Acute Disease; Animals; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Body Water; Brain; Chronic Disease; Diuresis; Hyponatremia; Male; Organ Size; Rats; Rats, Sprague-Dawley; Severity of Illness Index; Sodium; Tolvaptan; Urine | 2005 |
Vasopressin antagonists--progress and promise.
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Humans; Hyponatremia; Tolvaptan | 2006 |
Tolvaptan for hyponatremia.
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Heart Failure; Humans; Hyponatremia; Inappropriate ADH Syndrome; Liver Cirrhosis; Patient Dropouts; Tolvaptan; Water-Electrolyte Balance | 2007 |
Tolvaptan for hyponatremia.
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Humans; Hyponatremia; Liver Cirrhosis; Patient Selection; Prognosis; Tolvaptan | 2007 |
Tolvaptan for hyponatremia.
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Blood Volume; Humans; Hyponatremia; Hypovolemia; Inappropriate ADH Syndrome; Tolvaptan | 2007 |
Tolvaptan for hyponatremia.
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Blood Volume; Diuretics; Heart Failure; Humans; Hyponatremia; Inappropriate ADH Syndrome; Liver Cirrhosis; Tolvaptan | 2007 |
What new drugs can nephrologists look forward to in the next year or two?
Topics: Amides; Anemia; Antihypertensive Agents; Benzazepines; Drug Administration Schedule; Drug Approval; Drug Combinations; Drug Delivery Systems; Erythropoietin; Ferrosoferric Oxide; Fumarates; Humans; Hyponatremia; Immunosuppressive Agents; Kidney Diseases; Nanoparticles; Nephrology; Renal Dialysis; Renin; Tacrolimus; Tolvaptan | 2007 |